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Abstract 
Dietary food supplements are becoming increasingly popular and while many 
claim to aid weight loss, there is limited evidence to support such claims. 
Raspberry ketone and green coffee bean extract have both been marketed for 
weight loss and are often sold in a combined form. The aim of the present study 
was to test whether raspberry ketone and green coffee bean extract, when 
consumed separately and in combination, affect substrate utilisation and body 
composition. In a single blind randomised control trial, 32 healthy recreationally 
active males and females (age: 30.4 ± 1.5 years; BMI: 26.7 ± 0.4 kg.m-2; body 
mass: 79.0 ± 1.8 kg; V̇O2max: 37.7 ± 1.4 ml.kg-1.min-1) were randomly assigned to 
four different treatment groups for 8 weeks; raspberry ketone (RK) (200 
mg/day), green coffee bean extract (CGE) (400 mg/day), raspberry ketone plus 
green coffee bean extract (RK+CGE) (200 mg/day plus 400 mg/day) or control 
(200 mg/day). Resting metabolic rate, anthropometry, body composition and 
metabolic responses during a 30-minute steady state exercise test (55% V̇O2max) 
were measured at baseline and repeated post intervention. There was no effect 
of either supplement alone, or in combination on body mass (Baseline vs post 
intervention - RK: 82.5 ± 3.8 vs 81.6 ± 3.9, CGE: 81.1 ± 3.0 vs 81.0 ± 3.2, 
RK+CGE: 75.9 ± 3.8 vs 74.5 + 4.0, Control: 76.7 ± 4.1 vs 76.3 ± 4.2kg (p>0.05)) or 
body fat (Baseline vs post intervention - RK: 25.6 ± 3.3 vs 25.9 ± 2.7, CGE: 28.2 ± 
4.3 vs 28.7 ± 4.2, RK+CGE: 33.0 ± 3.8 vs 32.4 ± 3.7, Control 25.8 ± 3.6 vs 25.8 ± 
3.3% (p>0.05)). Similarly, no effect on substrate utilisation was observed either 
at rest (Baseline vs post intervention RER - RK: 0.83 ± 0.02 vs 0.84 ± 0.01, GCE: 
0.84 ± 0.02 vs 0.83 ± 0.01, RK+GCE: 0.85 ± 0.03 vs 0.82 ± 0.03, Control: 0.82 ± 
0.02 vs 0.84 ± 0.01 (p>0.05)) or during exercise (Baseline vs post intervention 
RER - RK: 0.89 ± 0.01 vs 0.87 ± 0.02, GCE: 0.90 ± 0.02 vs 0.90 ± 0.01, RK+GCE: 
0.85 ± 0.01 vs 0.84 ± 0.01, Control: 0.86 ± 0.02 vs 0.87 ± 0.02 (p>0.05)). In 
conclusion, this study demonstrated that 8-weeks of supplementation with 
raspberry ketone, green coffee extract and a combination of these supplements 
had no effect on body mass, body composition or substrate utilisation.  
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1 Introduction 
1.1 Obesity and Energy Balance 
Overweight and obesity represent a rapidly growing threat to the health of 
populations in an increasing number of countries (World health organisation 
(WHO) 2000). Obesity is defined medically as a state of increased body weight, 
more specifically adipose tissue, of sufficient magnitude to produce adverse 
health consequences. Worldwide obesity has almost tripled between 1975 and 
2016 (WHO 2018). The epidemic of obesity took off from the 1980s and has been 
increasing inexorably ever since, however only in 1997 did the World Health 
Organisation (WHO) recognised the importance of obesity and it is now treated 
as a major public health problem around the world (James 2008). A commonly 
used scale to categorise the degree of excess weight is the body mass index 
(BMI) scale, this is calculated by dividing the weight in kilograms by the square 
of the height in meters (kg/m2). The WHO defines overweight as a BMI equal to 
or more than 25 and obesity as a BMI equal to or more than 30 (World Health 
Organisation (WHO), 1995).  According to the recent worldwide health survey in 
2016, more than 1.9 billion adults, 18 years and over, were overweight, of these 
over 650 million were obese (WHO 2018). That equates to 39% of adults being 
overweight and 13% being obese. In Scotland alone, 65% of adults aged 16 and 
over are overweight (BMI > 25), including 29% who were obese (BMI > 30) 
(Scottish Health Survey. 2016). The prevalence is also seen in children, in 2016 it 
was reported 41 million children under the age of 5 were overweight or obese 
(WHO 2018). The UK’s Foresight analysis has projected that 60% and 40% of men 
and women, respectively, will be clinically obese by year 2050 (James 2008). 
Obesity and physical inactivity are clearly associated with increased mortality 
and adverse health outcomes, particularly an increased risk of developing 
cardiovascular disease and type 2 diabetes (T2D) (Sullivan et al. 2005; 
Warburton et al. 2006).  
Overweight and obesity are the result of an imbalance between energy intake 
and energy expenditure resulting in a positive energy balance. A negative energy 
balance is required for weight loss and this can be achieved by either decreasing 
energy intake or increasing energy expenditure, normally via lifestyle 
modifications such as diet and exercise. Energy intake consists of all food and 
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beverages with energy value and energy expenditure is represented by three 
major components; resting metabolic rate (RMR), physical activity and dietary 
induced thermogenesis (Spiegelman and Flier, 2001). Resting metabolic rate 
represents the largest portion of total energy expenditure, this is the energy 
associated with the maintenance of body functions and constitutes 60 to 75% of 
daily energy expenditure (Poehlman 1989). Thermogenesis is the energy 
expenditure associated with ingestion of food and constitutes around 10% of 
daily energy expenditure. Energy expenditure associated with physical activity is 
the most variable component and can constitute 15 to 30% of 24 hour energy 
expenditure (Poehlman 1989). When energy intake equals energy expenditure, 
energy balance is achieved and therefore body weight remains stable. Although, 
as simple as this concept may sound, it is often difficult for people to achieve 
this desired energy balance. However, it is not as simple as ‘eat less and 
exercise more’, other external factors such as stress and sleep quality/duration 
can also affect energy balance (Ogilvie et al. 2016). 
 
 
Figure 1. Key components of the energy balance system. 
(Spiegelman and Flier, 2001) 
  
1.1.1 Diet and Weight Loss 
As previously mentioned, a reduction in energy intake is required for weight loss 
to occur and this can be achieved in a variety of ways. A systematic review and 
meta-analysis of weight loss clinical trials reported eight types of weight loss 
interventions; diet alone, diet and exercise, exercise alone, meal replacements, 
very-low energy diets, weight loss medication and advice alone. They reported 
diet alone (51 studies of the total 80 studies in the review), diet and exercise, 
meal replacements and weight loss medication with diet produced the most 
encouraging short-term results (Franz et al. 2007). They reported that during the 
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first 6 months, studies involving diet alone experienced a mean weight loss of 
4.9kg, diet and exercise 7.9kg, meal replacements 8.6kg and weight loss 
medication 8.3kg, following this, weight loss begins to plateau across all 
interventions in the review. One of the ‘diet alone’ studies from the review 
investigated 78 obese females who followed either a ‘diet’ or ‘non-diet’ 
intervention for 6 months, with the ‘diet’ group reporting a reduction in body 
weight of 5.9 + 6.3kg compared to -0.1 + 4.8kg in the ‘non diet’ group (Bacon et 
al. 2002). A more recent systematic review and meta-analysis in 2017, 
investigating the effects of weight loss intervention in obese adults, also 
concluded weight reducing diets (usually low in fat), with or without exercise 
may reduce premature all-cause mortality in adults with obesity (Ma et al. 
2017). 
1.1.2 Physical Activity 
At the other end of the scale, an increase in energy expenditure can result in a 
negative energy balance, this can be achieved by increasing physical 
activity/exercise. Exercise, either alone or in combination with diet, can be 
fundamental in tackling overweight and obesity and the prevention and 
management of cardiovascular and metabolic diseases. However for weight loss, 
exercise alone is not as effective when compared to diet alone, although it can 
enhance the effects of a weight loss programme or as a prevention mechanism. 
In the systematic review by Franz et al, 2007, it was concluded that clinical 
trials investigating exercise-alone and advice-alone interventions reported 
minimal weight loss at any time point, with exercise alone trials reporting a 
mean weight loss of only 2.4kg. Findings from epidemiological studies, however, 
have consistently shown that regular physical activity prevents unhealthy weight 
gain and obesity (Saris et al. 2010), although the amount of physical activity 
require to prevent long-term weight gain is unclear. In 2010, Lee et al, 
examined the association of different amounts of physical activity with long-
term weight changes among women who consumed “usual” diet. From 1992-
2007, a cohort of 34,079 healthy women took part in the trial. The women 
reported their physical activity and body weight at baseline and months 36, 72, 
96, 120, 144 and 156. It was concluded that there was a significant interaction 
between BMI and physical activity levels, such that there was an inverse dose 
response relationship between activity levels and weight gain among women 
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with a BMI< 25, but no association in those with BMI>25. Over the 13 years 
follow-up, the women who maintained their normal body weight and gained 
fewer than 2.3kg were participating in, on average, 60 minutes of moderate 
intensity activity daily.  
The WHO has set recommended levels of physical activity to promote ‘healthy 
living’ in adult’s aged 18-64 years, their guidelines state that adults should do at 
least 150 minutes of moderate-intensity physical activity throughout the week or 
do at least 75 minutes of vigorous-intensity physical activity throughout the 
week or an equivalent combination of moderate and vigorous intensity activity 
and also do 2 sessions of muscle strengthening activities a week (WHO 2011). In 
2016, a health survey in Scotland reported that only 64% of adults met these 
recommended health guidelines (Scottish Health Survey. 2016). For preventing 
weight gain or regain, these guidelines are likely to be insufficient for many 
individuals. It is thought that 60-90 minutes of moderate intensity exercise, or a 
lesser amount of vigorous exercise, per day is required for prevention of weight 
gain (Saris et al. 2003), although further work is needed to confirm this. The 
combination of aerobic and resistance training has greater health benefits than 
doing only one form of exercise, these include improving body composition, 
muscular strength, glycaemic control and cardiovascular fitness (Maiorana et al. 
2002), and this would also be recommended for maintaining weight loss (Tsai 
and Bessesen, 2019). According to a report from the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines and 
The Obesity Society, the guidelines for management of overweight and obesity is 
a comprehensive lifestyle intervention including; prescription of a reduced-
calorie diet, at least 150 minutes of moderate-intensity physical activity per 
week (with 200–300 minutes for maintenance of weight loss per week), and 
behavioural strategies to achieve diet and physical activity targets (Jensen et al. 
2014). 
1.1.3 Alternative Weight Loss Methods 
As detailed above, commonly used methods for weight loss and control are 
dietary guidance, exercise and pharmaceutical approaches, which are often 
successful in the short term. However, long-term weight maintenance after 
weight loss is often unsuccessful due to lack of adherence to the lifestyle and 
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behavioural modifications. A recent study in 2016, investigated the long term 
effectiveness of a randomised, tailor-made lifestyle intervention consisting of 
diet (visits to the dietitian with tailor-made advice given, such as a low-fat or a 
low calorie diet, or both) and exercise (participation in physical activity classes 
such as dancing or low-intensity sports, such as Nordic walking or volleyball) (De 
Vos et al. 2016) in overweight females in primary care. The intervention lasted 
2.5 years, after the first 6 month, weight loss was significantly higher in the 
intervention groups, however after 24 months the difference decreased and 
became non-significant (De Vos et al. 2016). Possible reasons for this is a 
lifestyle change involving a behavioural modification of diet and/or exercise 
often requires effort, is time consuming, compliance is often poor, and the 
effects are only visible in the longer term, thus people seek alternative 
methods. These methods include meal replacements, dietary and nutritional 
supplements such as vitamins, minerals and botanicals, with these becoming 
increasingly popular as a wide variety of these products are available over the 
counter.  
In 2012, the dietary supplement industry in America reported sales greater than 
$32 billion (Garcia-Cazarin et al. 2014) and over $1.6 billion per year of this was 
due to weight-loss supplements alone (Spano and Antonio, 2008). Raspberry 
ketone and green coffee bean extract are reported as the most popular 
supplements for weight loss following heightened interest in the media 
(Bootsman et al, 2014). Some of the products available have been tested, 
individually, to assess their mechanisms of action and their ability to modulate 
fat metabolism. For example, green tea rich in phenolic compounds and caffeine 
have some evidence to support elevated fat oxidation at rest and during exercise 
(Hodgson et al. 2013, Hodgson et al. 2013). One of the often-cited mechanism 
regarding the effects of green tea on substrate utilisation is the metabolic 
pathway of green tea catechin degradation on O-methylation, which is catalysed 
by catechol-O-methyltransferase (COMT) (Hodgson et al. 2013). It is proposed 
that inhibition of COMT and the resulting increased and/or prolonged effects of 
norepinephrine, including increased energy expenditure and fat oxidation 
(Dostal et al. 2016). However, despite a number of studies observing positive 
effects in fat metabolism, overall the literature is inconclusive. A variety of 
nutritional supplements are often referred to as ‘fat burners’ and claim to 
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acutely increase fat metabolism or energy expenditure, increase weight loss, 
increase fat oxidation during exercise or somehow cause long-term adaptations 
that promote fat metabolism (Jeukendrup A.E and Randell R. 2011). However, 
the evidence supporting the effects of individual diet supplements on weight loss 
remains ambiguous and most marketing strategies for the supplements now focus 
on combined supplements to give ‘enhanced’ effects. Despite these claims there 
have been no studies to address the effects of combined supplement approaches 
to enhance rates of fat oxidation or weight loss. As many of these supplements 
purport to alter metabolism it is prudent, therefore, to briefly discuss the 
metabolic processes underlying the generation of energy. 
1.2 Metabolism 
Metabolism is typically subdivided into reactions in which chemical substances 
are broken down to generate energy, known as catabolism. Intracellular glucose 
and lipid metabolic homeostasis is vital for maintaining the basic life activities 
of a cell or an organism. Mitochondria are cellular organelles and are responsible 
for generating energy in the form of adenosine triphosphate (ATP). The 
generation of energy by the mitochondria involves several stages which are 
collectively known as cellular respiration, specifically aerobic respiration. In 
glucose metabolism, ATP is generated via glycolysis, the citric acid cycle, 
oxidative phosphorylation and the electron transport chain (Houston 1995). Lipid 
metabolism, involves lipid synthesis and oxidation through the processes known 
as lipogenesis and lipolysis respectively, and these will now be discussed in more 
detail. The interplay between glucose and lipid metabolism is summarised in 
figure 2. 
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Figure 2. Interplay between glucose metabolism and lipid metabolism. (Ward, 2015). 
 
1.2.1 Glycolysis 
Carbohydrate, in the form of glucose, is broken down to produce pyruvate in the 
cell cytosol in a metabolic pathway consisting of a series of enzyme-catalysed 
reactions known as glycolysis. The glucose needed for glycolysis comes mainly 
from ingestion of carbohydrates or from stored glycogen. The body also has a 
limited ability to produce glucose from non-carbohydrate sources, such as amino 
acids, lactate and glycerol, when carbohydrate stores are low through a process 
known as gluconeogenesis.  
Glycolysis is a pathway that can generate ATP, it generates a net production of 2 
ATP, and it also plays a major role in providing the substrates for the citric acid 
cycle in the form of pyruvate. Glycolysis occurs in the cytoplasm of cells and is 
governed by the energy need of the cell tissues containing glycogen include 
liver, skeletal muscle and heart muscle. When either glucose or glycogen are 
initially broken down, glucose 6-phosphate is produced, this process is then 
18 
 
followed by a series of 10 reactions (see figure 3), finally resulting in production 
of pyruvate. Under anaerobic conditions, pyruvate is reduced to lactate, or in 
aerobic conditions enters the mitochondria membrane where it is used as a fuel 
for oxidative phosphorylation (Houston 1995).  
 
Figure 3. Stages of Glycolysis with the structures of all the intermediates. (Berk et al. 2008). 
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1.2.2 The Citric Acid Cycle  
The citric acid cycle, also known as the tricarboxylic acid (TCA) or Krebs cycle, 
is a series of chemical reactions in which acetyl groups are oxidised to produce 
energy in the form of ATP. Under aerobic conditions, the pyruvate generated 
from glucose in glycolysis is converted to form acetyl CoA which then enters the 
citric acid cycle. The citric acid cycle is also tightly related to the electron 
transport chain as it removes electrons from the acetyl groups and attaches 
them to coenzymes NAD+ and FAD+, which are then fed into the electron 
transport chain, both these are linked to the rate of ATP utilisation (Houston 
1995).  
The citric acid cycle is a circular pathway catalysed by 8 enzymes (see figure 4), 
all of which are located in the mitochondrial matrix, except succinate 
dehydrogenase. It takes two turns of the cycle to process the equivalent of one 
glucose molecule. Acetyl groups containing two carbon atoms enter the 
pathway, one attaches to CoA and the other to oxaloacetate to form citrate. In 
the final reaction, malate results in the formation of oxaloacetate and NADH + 
H+, due to the oxidation by enzyme malate dehydrogenase, this starting 
substrate forms a new round of the cycle. The cycle produces three NADH 
molecules, one flavin adenine dinucleotide (FADH2) and ATP. The NADH and 
FADH2 produced from the cycle can then enter the electron transport chain for 
oxidative phosphorylation (Houston 1995). 
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Figure 4. The citric acid cycle with the structures of all the intermediates. (Ahern et al. 2019). 
 
1.2.3 Oxidative Phosphorylation 
Oxidative phosphorylation occurs in the mitochondria and is the formation of 
ATP from ADP and inorganic phosphate (Pi) in association with the transfer of 
electrons from NADH or FADH2 to oxygen by a series of electron carriers. It 
provides more that 85% of the ATP required, with the remaining arising from 
glycolysis. Oxygen is transported in the blood then delivered to the mitochondria 
following diffusion from the small capillaries into the cells. ATP synthesis occurs 
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in the inner mitochondrial membrane and is driven by the flow of protons back 
into the mitochondrial matrix in the electron transport chain (Houston 1995).  
1.2.4 Electron Transport Chain 
The electron transport chain is the last component of aerobic respiration and 
occurs on the inner membrane of the mitochondria. The chain comprises four 
complexes (I, II, III & IV) and a series of electron transporters, electrons are 
passed from donors to acceptors down the chain, releasing energy which is 
utilised to generate a proton gradient across the mitochondrial. Electrons from 
NADH and FADH2 pass through the protein complexes in the electron transport 
chain, in the fourth complex where the electrons are accepted by oxygen which 
then undergoes a reduction reaction, producing water. If oxygen is not present, 
the reaction does not occur. Hydrogen ions diffuse through the inner membrane 
through an integral membrane protein known as ATP synthase. The force from 
the hydrogen ion diffusion through the membrane protein regenerates ATP from 
ADP, this flow of hydrogen ions across the membrane through ATP synthase is 
known as chemiosmosis (Houston 1995). 
1.2.5 Glycogenolysis 
Glycogenolysis is the breakdown of glycogen to glucose-1-phosphate and 
glycogen (n-1), this takes place in muscle and liver cells when energy demands 
need to increase due to low levels of ATP. Glycogen is broken down to glucose-1-
phosphate, the enzyme phosphoglucomutase converts this to glucose 6-
phosphate, which can then be used to produce ATP. In muscle cells glucose 6-
phosphate is an immediate source for glycolysis and in the hepatocytes of the 
liver glucose is released into the bloodstream for uptake by other cells. 
Glycogenolysis is regulated by hormones in response to blood sugar levels, the 
hormones glucagon and insulin in the blood raise and lower glucose levels 
respectively. In addition, it is stimulated by epinephrine, a hormone produced 
during a time of stress or when the bodies ‘fight-or-flight’ response is activated 
(Houston 1995).  
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1.2.6 Lipolysis 
Lipolysis is one of the most important metabolic pathways regulating adipose 
tissue mass and thus obesity. The stored form of fat (or lipids) found in 
adipocytes and striated muscle is known as triacylglycerol (TAG) and consists of 
a glycerol molecule that is bound to three long-chain fatty acids (FA). Fatty acid 
chains are carbon molecules with hydrogen atoms linking the chains together. 
Lipolysis is known as the breakdown process of these TAG to form FA and 
glycerol, this is regulated by hormone sensitive lipase (HSL), resulting in the 
release of FA, into the blood, which can then be transported to the working 
muscle for oxidation. When FA enter the blood stream they attach to a blood 
protein called albumin, these are known as free fatty acids (FFA). For this to 
occur the FA are converted to fatty acyl CoA then transported into the 
mitochondrial matrix by attaching to carnitine. Fatty acid molecules are broken 
down to generate acetyl-CoA in a process known as beta oxidation, this reaction 
releases acetyl CoA, FADH2 and NADH, which can then feed in to the citric acid 
cycle. Lipolysis is promoted by epinephrine, norepinephrine, thyroid hormone 
and growth hormone, whereas it is inhibited by insulin. Lipogenesis is the 
process in which acetyl CoA is converted to form TAG. It encompasses the 
process of fatty acid synthesis and triglyceride synthesis, where FA are esterified 
to glycerol (Houston 1995). 
1.2.7 Fat and Carbohydrate Oxidation  
Fat and carbohydrate are the fuels most used as an energy source at rest and 
during exercise. Fat is stored in the form of TAG in subcutaneous adipose tissue 
and muscle and carbohydrate is stored as glycogen in muscle and liver. At rest, 
skeletal muscle is the main site of oxidation of fatty acids, especially in the 
fasted state, with carbohydrate oxidation making only a small contribution. 
Carbohydrate and fat are predominantly oxidised simultaneously however the 
relative contribution of these substrates depends on a number of factors, 
including exercise intensity, duration, diet and training status (Achten and 
Jeukendrup, 2004). Fat oxidation is relatively high during low-moderate intensity 
exercise, where metabolism is elevated. It has been reported that maximal fat 
oxidation (Fatmax) rates typically occurs at 45-65% V̇O2max (Achten and 
Jeukendrup, 2004), after which a decline in the relative rate of fat oxidation is 
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observed at higher exercise intensities. This is in contrast to carbohydrate 
oxidation, which increases as a function of the aerobic work rate.  
Over the past few decades research has focused on interventions and strategies 
to increase rates of fat oxidation both at rest and during exercise, these include 
exercise training interventions (Achten and Jeukendrup, 2004), high-fat diets 
and low carbohydrate diets (Kian Yeo et al. 2011), and more recently dietary 
food supplements (Jeukendrup and Randell, 2011). There is a plethora of dietary 
and food supplements that are available on the market that purport to enhance 
weight loss through suppression of appetite and enhance metabolism, although 
evidence in support of their use is often lacking. Many aspects of the 
aforementioned metabolic processes are hypothesised to be altered by 
commonly used weight loss supplements and some of the most common 
supplements will now be discussed. 
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1.3 Weight Loss Supplements 
1.3.1 Raspberry Ketone 
Raspberry Ketone [4-(4-hydroxyphenyl)-2-butanone] is one of the major aromatic 
compounds of red raspberry (Rubus idaeus) and has for a long time been used for 
nutritional and medicinal purposes. Raspberries contain an abundance of sugars 
vitamins, mineral, polyphenols and antioxidants, similar to that of the 
strawberry and blueberry. Raspberry ketone is widely used as a fragrance in 
perfumery and cosmetics and by the food industry as a flavouring substance in 
foodstuffs (Yurie 2003). The content of raspberry ketone in one kilo of 
raspberries can range from 0.009 to 4.3 mg/kg (Meister 2016), for an adult, the 
daily exposure of this from fruits and flavourings alone has been estimated to 
range between 1.8 and 3.8 mg/day (Crispim et al.  2010). With the 
concentration of naturally occurring raspberry ketone being limited and the 
extraction process being expensive, raspberry ketone can be synthesised 
chemically via the condensation of p-hydroxybenzaldehyde with acetone or 
biosynthesised in genetically modified micro-organisms such as bacteria or yeast 
(Beekwilder et al. 2007; Serra et al. 2005).  
Raspberry ketone is marketed by food supplement suppliers with the daily dose 
ranging from 100 to 1400 mg/day, this is between 26 and 368 times higher than 
normally obtained from daily diet (Bredsdorff et al. 2015). The structure of 
raspberry ketone is similar to the structure of capsaicin and p-synephrine (see 
figure 5), compounds known to exert anti-obesity actions and alter lipid 
metabolism. Capsaicin (N-[(4-hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-
nonamide), is a primary component of the red chilli pepper and has a 
thermogenic ingredient which stimulates energy expenditure. It was reported by 
Kawada et al. (1986), to decrease adipose tissue weight and serum TAG content 
by enhancing metabolism in rats through decreased glycogen in the liver, 
increased serum glucose concentrations and increased free fatty acids levels. In 
humans, several studies have shown that capsaicin stimulates thermogenesis by 
increasing energy expenditure (Lejeune et al. 2003; Yoshioka et al. 1998). In 
1998, Yoshioka et al, investigated the effects of adding red pepper to a diet, 
under four diet conditions. Women were fed either a high fat diet, high fat diet 
plus red pepper, high carbohydrate diet or a high carbohydrate diet plus red 
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pepper. Following the allocated meal expired air samples were collected at 
every 10 min for the first hour after the experimental meals and then every 30 
min from 90 min to 210 min after the experimental meals. Results showed the 
addition of the red pepper to the meal significantly increased diet-induced 
thermogenesis and fat oxidation, especially in the high fat diet group, resulting 
in a lower RQ compared with the control meals between 30 and 60 min 
postprandial. Furthermore, Lejeune et al, 2003 reported the effects of capsaicin 
on substrate oxidation and weight maintenance following a 4 week very-low-
energy diet to induce weight loss (average of 7.8 + 1.8 % weight loss). The 
randomised control trial had 91 overweight subjects split into two groups; 
capsaicin (135mg/day) or placebo group (225mg vegetable oil), subjects took the 
capsules for a 3-month weight maintenance period. At the end of the 3 month 
period there was no difference in mean percentage of weight regain, however 
there was a significant increase in fat oxidation in the capsaicin group. A more 
recent study by Janssens et al., in 2013, investigated the effects of capsaicin on 
24 hour energy expenditure, substrate oxidation and blood pressure, measured 
in a respiratory chamber. Subjects underwent four 36 hour sessions; eating 100% 
or 75% of their daily energy requirements plus the addition of either capsaicin 
(2.56mg) or control with every meal. They found that by reducing the negative 
energy balance by 25%, fat oxidation rates were higher in the 75% capsaicin 
group compared to the 100% control group. 
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Figure 5. Structural compounds, comparing Capsaicine, P-Synephrine and Raspberry 
Ketone. (Morimoto et al. 2005) 
 
Similarly, p-synephrine (I-(4-hydroxy-phenyl)-2-methylaminoethanol), a 
compound in citrus plants including bitter orange, exerts a lipolytic activity in 
fat cells (Carpéné et al. 1999). There have been a few studies investigating the 
effects of p-synephine when combined with exercise. A study in 2016, twelve 
healthy men performed a control resistance exercise protocol (6 × 10 repetitions 
of squats) and were randomly assigned (using a double-blind crossover design 
with random protocol sequencing) to a supplement sequence: p-synephrine (S; 
100 mg), p-synephrine + caffeine (SCF; 100 mg of p-synephrine plus 100 mg of 
caffeine), or a placebo (P).  The author reported that the number of repetitions 
during squat resistance exercise increased following the ingestion of 1.2 mg/kg 
of p-synephrine for 3 consecutive days. In addition, 30 minutes post-resistance 
exercise, energy expenditure increased throughout the 30 minutes (CT = 2.82 ± 
0.3; P = 2.81 ± 0.5; S = 2.98 ± 0.3; SCF = 2.97 ± 0.3 kcal/min-1) and fat oxidation 
rates increased between 25-30 minutes (S = 0.200 ± 0.04; SCF = 0.187 ± 0.06 
compared to P = 0.166 ± 0.05 g/min-1) (Ratamess et al. 2016). A recent study in 
2018 investigated the dose-response effects of p-synephrine on maximal fat 
oxidation during exercise. The randomised control trial involved 17 subjects 
allocated to four experimental groups; 1, 2 or 3 mg/kg of p-synephrine or a 
placebo (cellulose). Subjects performed an incremental exercise test on a cycle 
ergometer until exhaustion with expired gas being continuously measured. All 
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the doses of p-synephrine were found to increase maximal fat oxidation during 
exercise compared with the placebo (0.47 ± 0.11 vs 0.35 ± 0.05 g/min), the 
highest effects were found with 2 and 3 mg/kg (0.55 ± 0.14 g/min), there was no 
change in the intensity at which V̇O2max was obtained between the groups 
(Gutiérrez-Hellín and Del Coso, 2018). In addition, a previous study by Gutiérrez-
Hellín and Del Coso, in 2016, reported that a similar dose of 3 mg/kg of p-
synephrine did not result in any improvement in physical performance in elite 
sprinters during maximal running and jump tests. Therefore, with raspberry 
ketone being structurally similar to both capsaicin and p-synephrine, it could be 
hypothesised that raspberry ketone would also influence the lipid metabolism on 
adipocyte.  
1.3.1.1 Current Literature 
The current literature on raspberry ketones focuses on either in vitro or in vivo 
studies. An in vitro study using adipocytes (fat cells) investigated the effects of 
raspberry ketone on both lipolysis and fatty acid oxidation in 3T3-LI adipocytes, 
it was observed that treatment with 10 µM of raspberry ketone (99% purity), 
premixed with culture medium, increased lipolysis and fatty acid oxidation, 
suppressed lipid accumulation, and increased both the cellular and the secretion 
levels of adiponectin (Park 2010). The lipolytic effect of the cells treated with 
10 µM of raspberry ketone induced a 3-fold greater release of glycerol into the 
culture medium compared to the control and the fatty acid oxidation levels of 
palmitic acid were assessed, reporting a significantly higher degree of oxidation 
in the cells pre-treated with raspberry ketone compared to the control (Park 
2010). Similarly, a further study by Park, in 2015 investigated the effects of 
raspberry ketone on the adipogenic and liopgenic gene expression in adipocytes 
in mice and concluded raspberry ketone (10 µM) inhibits the process of adipocyte 
differentiation, as they reported a reduction in the expression of genes involved 
in adipogenesis and lipogenesis. In addition, it was reported that raspberry 
ketone enhanced the expression of genes involved in lipolysis, and fatty acid 
oxidation, including HSL and adipose triglyceride lipase (ATGL) (Park 2015), 
these finding are consistent with the previous finding from Park in 2010. 
Meanwhile, in vivo studies in male mice, where mice were fed either a high-fat-
diet including 0.5,1 or 2% of raspberry ketone (99% purity) for 10 weeks or a 
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high-fat-diet for 6 weeks and then fed the same high-fat-diet this time 
containing 1% raspberry ketone (HFD + (HFD + 1%) for the next 5 weeks 
(Morimoto et al. 2005). It was reported that raspberry ketone prevented high-fat 
diet-induced increases in body weight, visceral adipose tissue weight  and the 
weight of the liver as shown in the HFD + (HFD + 1%) group. Raspberry ketone 
supplementation also decreased hepatic TAG content after they had been 
increased from the initial high-fat diet. They reported raspberry ketone 
supplementation significantly increased norepinephrine-induced lipolysis in 
white adipocytes and enhanced thermogenesis in brown adipose tissue, this was 
measured by the amount of glycerol released into the medium and could explain 
the findings of this anti-obesity effect (Morimoto et al.  2005). These results 
indicate that raspberry ketone prevents and improves obesity and fatty liver 
induced by feeding a high-fat-diet.  Similarly, Meng et al. (2008) reported 
raspberry ketone could reduce the weight of obese rats fed high-fat-diets. They 
suggest that by mediating lipid disorders; like improving insulin resistance and 
reversing leptin resistance, this could exert an anti-obesity function. In 2011, Lili 
et al investigated the possible mechanism of raspberry ketone on obesity and 
the influence of resistance on obesity relevant insulin in rats. The study 
randomly divided 40 rats into 5 groups; normal fed with normal diet (NC), model 
control fed with high fat diet (MC), raspberry ketone low-does (RKL), raspberry 
ketone medium-does (RKM) and raspberry ketone high-does (RKH) groups fed 
high fat diet plus 0.5%, 1% and 2% of raspberry ketone for 4 weeks. After 8 weeks 
they reported the RKM and RKL observed significant decreases in FFA, LEP and 
tumor necrosis factor-α (TNT-α), and all RK groups showed significant reductions 
in blood glucose and decreased insulin levels compared to MC, therefore it was 
hypothesised the anti-obesity function was seen through combined effects of 
improving insulin resistance (Lili et al. 2011).   
On the other hand, it has been reported that raspberry ketone improve leptin 
resistance and inhibit lipid peroxidation and modulating inflammatory responses 
when raspberry ketone is used as a treatment against non-alcoholic 
steatohepatitis (‘fatty liver’) (Wang et al. 2012). They investigated 5 groups of 
rats; normal control group (NC) (fed normal diet for 8 weeks), model control 
group (MC) (fed a high fat diet) and 3 groups with different doses of raspberry 
ketone (0.5% RKL, 1% RKM and 2% RKH + high fat diet for 4 weeks). The liver 
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tissues of rats in each group were analysed, comparing all 3 doses of raspberry 
ketone against the control group. All parameters measured reported significant 
improvements; these included, triglycerides, low-density lipoprotein cholesterol 
(RKL 18.6 ± 0.60; RKM 20.0 ± 1.00; RKH 18.7 ± 0.58  vs NC 21.2 ± 0.62 ng/L), , 
leptin RKL 2.83 ± 0.77; RKM 3.00 ± 0.83; RKH 4.77 ± 1.61  vs NC 2.41 ± 0.57 
ng/mL), blood glucose (RKL 6.48 ± 1.10; RKM 6.31 ± 1.10; RKH 6.24 ± 1.36  vs NC 
5.80 ± 1.44 mmol/L), insulin (RKL 3.49 ± 0.13; RKM 3.99 ± 0.12; RKH 3.96 ± 0.25  
vs NC 3.49 ± 0.12 µIU/mL) and free fatty acids (RKL 87.35 ± 19.48; RKM 119.73 ± 
24.92; RKH 132.00 ± 52.65  vs NC 83.63 ± 18.29 µg/L). They concluded raspberry 
ketone to be an effective intervention for fatty liver in rats who were fed a high-
fat-diet.  
These reports indicate raspberry ketone has a duel effect on fat reduction and 
liver protection. The mechanisms reported include decrease in adipose tissue 
degeneration in liver cells, reduction of liver inflammation, and correction of 
dyslipidaemia, reversal of leptin and insulin resistance and improved antioxidant 
capacity. A more recent study in 2017 investigated the effects of raspberry 
ketone on accumulation of adipose mass, hepatic lipid storage and levels of 
plasma adiponectin in mice fed a high fat diet. Firstly mice were fed a high fat 
diet for 2 weeks to induce weight gain, following this they were randomly 
assigned to four experimental groups; high-dose raspberry ketone (HRK, 1.74% 
RK wt/wt), low-dose raspberry ketone (LRK, 0.25% RK wt/wt), control and pair 
fed (PF) group, fed a similar food intake to the LRK mice. Mice were then fed for 
five weeks, results showed that mice fed LRK and HRK diets showed reduction in 
food intake and body weight compared to mice on the control diet, the HRK diet 
exhibited decreases in inguinal fat mass and increased liver mass compared to 
the control group. However, plasma adiponectin concentration levels were not 
affected by raspberry ketone, reporting no significant changes between the 
groups (Cotton et al. 2017), opposing the earlier findings by Park, 2010. Previous 
studies (Park 2010) have hypothesised the mechanism which results in raspberry 
ketone reducing body mass is from increasing adiopenctin levels, however 
Cotton et al (2017) reported reduction in body weight with no differences in 
plasma adiopnectin. While there have been some reported studies of the effects 
of raspberry ketone in rats and mice and their possible mechanisms, with the 
limited number of studies in humans the relevance could be debated.  
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1.3.1.2 Clinical Trials 
In the last few years, raspberry ketone has been sold as an ingredient in food 
supplements where it is claimed to have a slimming effect and has been 
considered within alternative weight loss management; however, to date there 
has been no clinical evidence available on such claims. A randomised, placebo-
controlled study by Lopez et al (2013) investigated a multi-ingredient weight loss 
supplement (METABO), with raspberry ketone being one of the ingredients, 
although the exact concentration is unclear, and other ingredients included 
caffeine, capsaicin, ginger and citrus. The trial investigated the effects of an 8-
week diet and exercise program; a calorie restricted diet with a deficit of 500 
kilocalories per day and performed three, 60-minute exercise sessions per week 
and included a daily supplementation (with either METABO or placebo). 
Significant differences in body composition were observed, compared to the 
placebo group, the participants in the METABO group reporting a -2% decrease in 
body weight with the placebo group reporting a -0.5% decease, fat mass (-7.8% 
versus -2.8% P < 0.001), waist girth (-2.0% versus -0.2% P < 0.0007) hip girth (-
1.7% versus -0.4% P < 0.003) and an increase in lean mass (+3.4% versus +0/8% P 
< 0.03) (Lopez et al. 2013). Lopez et al, proposed a possible mechanism for the 
anti-obesity effects of raspberry ketone could be via an enhanced production of 
norepinephrine, resulting in an increase in the hormone-sensitive lipolytic action 
of lipolysis. Prior to the 2013 study by Lopez et al, the same research group 
carried out a preliminary trial and reported similar results. They carried out an 8 
week intervention on 70 men and women who randomly ingested either METABO 
4 x capsules/day or a placebo alongside a calorie restricted diet and supervised 
exercise training. The details of the pre and post testing was not described, 
however body composition, waist and hip girth and energy levels were 
measured. Significant difference were reported in the METABO group for body 
weight (-2.0 vs -0.5 %); fat mass (-7.8 vs -2.8 %); waist girth (-2.0 vs -0.2 %); hip 
girth (-1.7 vs -0/4 %) and energy levels (+29.3 vs +5.1 %) (Hofheins et al. 2012). 
Furthermore, a more recent study in 2018 by Argent et al, investigated the same 
multi-ingredient weight loss supplement (METABO) in overweight men and 
women. The trial was a randomised, placebo controlled, double blind study 
where participants consumed 4 capsules/day of either METABO (n=18) or placebo 
(n=18). Following 8 weeks of supplementation alongside a calorie restricted diet 
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(500 Kcal < RMR) and supervised exercise training 3 times a week; body 
composition, girth and serum adipokines levels were assessed. Across both 
groups, significant decreases in weight (-2.6 ± 0.57 kg), fat mass (-1.8 ± 0.20 kg), 
percentage body fat (-3.7% ± 0.29%) and significant increase in lean body mass 
(1.5 ± 0.26 kg) were reported. They observed that only men in the METABO 
group reported increases in lean body mass (1.3 ± 0.38 kg) and only women in 
the METABO group reported reduced hip girth (-10.7 ± 2.15 cm). A significant 
increase in adiponectin in the METABO group was also reported. It was 
hypothesized that the raspberry ketone within the METABO supplement may 
have been responsible for the increase in adiponectin, following the report in 
2010 by Park, in which raspberry ketone was reported to increase both the 
expression and the secretion of adiponectin in cell cultures. With most of the 
current research coming from either in vitro or in vivo studies, more evidence is 
needed to support these claims in humans and the mechanisms by which 
raspberry ketones can increases in fat oxidation and possible weight loss. 
1.3.2 Green Coffee Bean Extract 
Green coffee extract (GCE) is derived from green unroasted coffee beans, it is 
also found in both raw and roasted coffee, although much of the green coffee 
extract is destroyed in the roasting process of coffee. It is marketed in both 
caffeinated and decaffeinated forms. Polyphenols are well known antioxidants 
that protect body tissues against damage and prevent disease associated with 
oxidative stress and its related complications. The glycosylated derivate forms of 
polyphenols, chlorogenic acids (CGA) are the main polyphenols in green coffee 
bean extract, these can also be found in a variety of fruit and vegetables 
(Manach et al. 2004). Chlorogenic acids are a family of esters that are formed by 
quinic acid and several hydroxycinnamic acids, particularly caffeic, ferulic and 
p-coumaric acids. The most common chlorgenic acids are 5-O-caffeoylquinic 
acid, 2-O- caffeoylquinic acid and 4-O- caffeoylquinic acid. Chlorgenic acid is 
present, to some extent, in roasted coffee, although much of it is destroyed in 
the roasting process. The typical daily intake of chlorogenic acid from drinking 
coffee varies from 0.5 to 1g (Clifford 1999). Green coffee extract has been used 
as a weight-loss supplement and as an ingredient in other weight-loss products, 
it has been marketed under a variety of brand names such as “Coffee Slender”, 
and “Svetol”.  
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Figure 6. The chemical structure of chologenic acid (CGA) (Naveed et al. 2018) 
 
1.3.2.1 Current Literature 
There has been increasing evidence from animal studies regarding the use of 
green coffee extract as a weight loss supplement. Several studies reported green 
coffee extract (doses ranging from 50-400 mg/kg) to reduce visceral fat content 
and body weight after being administered to mice following both a standard fed 
diet and a high-fat diet. Shimoda et al. 2006 reported these results after 14 days 
of administration of green coffee bean extract (100, 200 and 400 mg/kg/day), 
Choi et al. 2016 similarly reported; after initially inducing obesity via four weeks 
of a high-fat diet, mice were then divided into five groups; fed only high fat 
diet, high fat diet with green coffee extract (50, 100 and 200 mg/kg) for six 
weeks alongside a high-fat diet, and a normal fat diet alone being the control 
group. In high fat induced obese mice it was reported that treatment with green 
coffee bean extract (100 and 200 mg/kg) significantly decreased weight gain, 
liver weight, FFA and white adipose tissue weights with regulation of adipose 
tissue hormones like leptin and adiponectin. Green coffee bean extract fed mice 
observed levels of adiponectin, HSL, ATGL and PPARα were significantly 
upregulated in a dose response manner. Compared to the mice fed only a high 
fat diet, the green coffee bean extract treated mice had a lower fat mass and 
relative body weight, it was thought that this lower body fat accumulation may 
be regulated by lipid metabolism related genes and adipogenesis 
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Another study comparing the efficacy of chlorogenic acid (0.02% wt/wt) in 
altering body fat in high-fat diet induced-obese mice compared to caffeic acid 
found comparable results to the previous studies, reporting both phenolic acids 
(caffeic acid and chlorogenic acid) improved body weight (body weight gain; 
high caffeic acid 15.45 ± 1.07; high chlorogenic acid 11.79 ± 0.97 vs high fat 
control 18.50 ± 1.32 g), , with chlorogenic acid seeming to be the more potent 
for body weight reduction and regulation of lipid metabolism. It was reported 
that both chlorogenic acid and caffeic acid significantly lowered plasma leptin 
(high caffeic acid 3.32 ± 0.34; high chlorogenic acid 2.52 ± 0.15 vs high fat 
control 5.58 ± 0.50 ng/mL), insulin levels (high caffeic acid 5.21 ± 0.33; high 
chlorogenic acid 4.86 ± 0.45 vs high fat control 6.93 ± 0.25 ng/mL), and fatty 
acid synthase when compared to the high fat control group, while they increased 
fatty acid β-oxidation (high caffeic acid 5.43 ± 0.65; high chlorogenic acid 7.24 ± 
0.47 vs high fat control 3.41 ± 0.54 nmol/min/mg/protein). Triglyceride content 
in the adipose tissue was lowered significantly, whereas the plasma 
concentration of adiponectin was increased in the chlorogenic acid group 
compared to the high fat control group. (Cho et al. 2010). Similar findings of 
Huang et al. (2015) reported that chlorogenic acid can supress high fat diet 
induced increases in body weight, visceral fat and serum lipid levels and serum 
and hepatic free fatty acids. Furthermore in 2014, Song et al. reported that 
decaffeinated green coffee extract significantly reduced visceral fat-pad 
accumulation in the mouse model of obesity, they concluded this may be due to 
a decrease in adipogenesis and inflammation in the white adipose tissues.  
Caffeinated green coffee extract has also been reported to potentially reduce 
body weight, Tanaka et al. in 2009 investigated the effects of treating 4-week-
old rats with green coffee extract (diet containing 1%) rich in caffeine (10%) and 
chlorogenic acid (27%) for 4 weeks. In the green coffee extract treated rats, 
body weight gain and white adipose tissue weight were significantly reduced 
compared to the control rats, although there was no difference in food intake 
between the diet of the control group without green coffee extract and the rats 
fed the green coffee extract. They reported serum and liver triglyceride 
concentration were significantly reduced in the green coffee extract fed rats 
compared to the control and further to this there was also an increase in fatty 
acid oxidative enzymes in the hepatic mitochondria, however these observations 
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could be due to the caffeine and not the green coffee extract. Moreover, a study 
investigated the effects of a decaffeinated green coffee extract ‘Svetol’ on diet-
induced insulin resistance and brain energy metabolism dysfunction in a high-fat 
diet mouse model. In the study mice were assigned to one of four groups; high 
fat diet, high fat diet + Svetol, normal diet and normal diet + ‘Svetol’ for 5 
months. Oral glucose tolerance tests determined changes in the circulating 
glucose levels and it was reported that supplementation with ‘Svetol’ 
significantly attenuated the development of high fat diet induced insulin 
resistance, reflected by improving glucose clearance. ‘Svetol’ treatment also 
improved brain energy metabolism as determined by oxygen consumption rate. 
However, unlike previous studies mentioned, it was observed that ‘Svetol’ had 
no effect on body weight under the context of both a normal diet and a high fat 
diet.  
On the other hand, Li et al. in 2014 investigated the effect of green coffee 
extract on obesity, glucose tolerance, insulin resistance, systemic oxidative 
stress and endothelial dysfunction in a mouse model of the metabolic syndrome. 
Mice were randomly divided into 3 groups;  normal diet (ND),  high fat diet (HFD) 
or a high fat diet supplemented with green coffee extract rich in chlorogenic 
acid (0.5% w/w) (HFD + GCE) and fed this diet for 12 weeks. Both the HFD and 
HFD + GCE groups displayed symptoms of the metabolic syndrome compared to 
the ND groups, although no endothelial dysfunction was observed. GCE did not 
attenuate HFD induced obesity, glucose intolerance, insulin resistance or 
systemic oxidative stress. In 2008, a study by Bassoli et al, they investigated the 
effects chlorogenic acid on blood glucose levels and glucose tolerance in rats. It 
was found that chlorogenic acid promoted a significant decrease in the plasma 
glucose peak in the oral glucose tolerance test, most likely by attenuating 
intestinal glucose absorption, indicating a possible role for chlorogenic acid as a 
glycemic index lowering agent.  
A study in 2014 investigated the lipolytic activity of varying concentrations of a 
decaffeinated green coffee extract known as ‘Svetol’ (0.01mg/mL, 0.1 mg/mL 
and 1.0mg/mL) on the liberation of free fatty acids from human adipocytes 
following short term (2 hours) or long term (192 hours) exposure (Flanagan et al. 
2014). The results showed that long term exposure with 0.1 mg/mL & 1.0mg/mL 
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concentration of ‘Sevtol’ increased the release of free fatty acids from human 
adipocytes compared to the control. 
1.3.2.2 Clinical Trials 
Clinical trials investigating the effects of green coffee bean extract in humans 
are limited with mixed findings, however, a number of trials have demonstrated 
the effects of green coffee extract, containing chlorogenic acid, with positive 
reports with regards to weight loss and weight management as well as regulation 
of blood glucose levels (Thom 2007; Dellalibera et al. 2006). Thom, 2007 
investigated the effects of chlorogenic acid enriched coffee on glucose 
absorption (study 1) in 12 healthy volunteers and the effects on body mass 
(study 2) on 30 overweight individuals (BMI 27.5 to 32 kg/m2) over a 12-week 
period. The chlorogenic acid enriched coffee contained 200 mg per 2200 mg of 
the ‘Coffee Slender’, of this 200 mg, 90-100 mg contained chlorogenic acids (45-
50%) compared to caffeinated and decaffeinated instant coffee containing 30-40 
mg/g of chlorogenic acid (45-50%). Study 1 involved the intake of four different 
beverages for 12 weeks; glucose solution (control), ‘Coffee Slender’, instant 
coffee (caffeinated) and instant decaffeinated coffee. The result from the oral 
glucose tolerance test reported that the ‘Coffee Slender’ significantly reduced 
the absorption of glucose by 6.9% compared to the control, there was no 
significant difference reported between the two instant coffee groups compared 
to the control. Study 2 involved the intake of either ‘Coffee Slender’ of instant 
coffee (caffeinated) for 12 weeks, results reported average losses in body mass 
from the coffee slender group were 5.4kg compared to 1.7kg in the instant 
coffee (caffeinated) group with body fat reductions of 3.6% compared to 0.7%.   
In addition, Dellalibera et al. 2006 investigated the effects of decaffeinated 
green coffee extract known as ‘Svetol’, a decaffeinated green coffee extract; 
that has high chlorogenic acid content, on weight loss and lean-to fat mass 
ratios. The intervention involved 50 overweight volunteers (BMI >25) consuming 
either 2 capsules per day of ‘Svetol’ (200 mg) or placebo for 60 days. Results 
showed a mean significant reduction in weight was observed in the ‘Svetol’ 
group (4.97 + 0.32 kg, 5.7%) compared to the control group (2.45 + 0.37 kg, 
2.9%) (P < 0.05). The lean-to fat mass ratio was significantly increased in the 
‘Svetol’ group (4.1 + 0.7%) compared to the control group (1.6 + 0.6%) (P < 
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0.05), consequently lowering the BMI. Moreover, the ratio of muscle mass to fat 
mass (MM/FM) was increased significantly in the ‘Svetol’ group compared to the 
control (4.1 ± 0.7 % vs 1.6 ± 0.6 %), which was determined by bioelectrical 
impedance. They stated that ‘Svetol’ “is able exacerbate the effects of a bland 
low calorie diet in volunteer who are overweight” and this could be due to the 
increasing consumption of fatty deposits, as shown by the changes in MM/FM 
ratio, and therefore preventing them from being accumulated. 
Furthermore, a randomised pilot crossover trial of 18 healthy volunteers (BMI 
24.23 ± 4.6 kg/m2), investigated the effects of green coffee on body composition 
and blood pressure, where participants either consumed green coffee rich in 
chlorogenic acid (GC - 40g per cup per day, 4 times per day, % of chlorogenic 
acid unknown) or black coffee (BC -40g per cup per day, 4 times per day) for two 
weeks. Consumption of green coffee rich in chlorogenic acid resulted in 
significant effects on weight and BMI (P = 0.01 for both parameters), at baseline 
weight and BMI were 70.52 + 15.89 kg and 24.23 + 4.6 kg/m2, this was 
significantly reduced to 69.13 + 15.9 kg and 23.95 + 4.78 kgm2 in the green 
coffee group. GC group significantly reduced waist circumference (1.74 vs 0.89 
cm P = 0.009), abdominal fat (1.75 vs 1.44 % P = 0.015), systolic blood pressure 
(2.65 ± 1.37 mmHg) and diastolic blood pressure (2.23 ± 1.44 mmHg) compared 
to the BC group (Revuelta-Iniesta and Al-Dujaili 2014).  
A key observation with these studies is their investigation tends to involve 
overweight or obese individuals, there is less evidence to investigate the use of 
green coffee extract for weight loss on normal-weight individuals without a 
medical condition, for example hypertension (Kozuma et al. 2005, Watanabe et 
al. 2017). Although these studies have reported green coffee extract has 
promising for potentially preventing and treating overweight and obesity, two 
meta-analysis and systematic reviews on the use of green coffee extract as a 
weight loss supplement have identified considerable heterogeneity with some of 
the studies mentioned (Onakpoya et al. 2011; Hausenblas and Huynh, 2014). 
Apart from the small sample size, there seems to be an association with a high 
risk of bias. Studies previously mentioned by Thom and Dellalibera were not 
clear on their blinding or how the randomisation was carried out and there was 
no information on blinding of outcome assessors, the internal validity of these 
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trials may prove doubtful. The 2006 study by Dellalibera et al, has two authors 
affiliated to the company which marketed ‘Svetol’, they did not declare any 
conflicts of interest.  
On the other hand in a study by Kotyczka et al. (2011), no significant changes in 
body weight were reported following the consumption of chlorogenic acid-rich 
coffee. This was a randomized, longitudinally designed 12 week intervention 
where 30 volunteers firstly administered 500ml of a light roast coffee (with high 
concentrations of chologenic acid 4.5mmol/l) for 4 weeks, this was followed by a 
2 week wash out period. Following the wash out period volunteers then 
administered the same volume of a dark roast coffee (chologenic acid 
concentration of 0.05mmol/l) for 4 weeks. Body mass was reported pre and post 
both 4 weeks interventions, they reported the chologenic acid rich coffee 
resulted in a significant increase in body mass (0.2 + 0.5kg). The dark roast 
coffee which was rich in N-methylpyridinium ions, reported a significant 
decreass in body mass of 0.6 + 0.4kg. Compared with previous studies this trial 
was relatively short with only 4-weeks of consumption been investigated.  
The effects of green coffee bean/chlorogenic acid on energy metabolism in 
humans has not been sufficiently investigated. A study in 2013 by Soga et al, 
investigated the effects consuming chlorogenic acid on energy metabolism in 18 
male subjects. The study was a double blind, placebo-controlled, crossover trial 
where subjects consumed two different beverages daily, one chlorogenic acid 
(329mg/185g) containing beverage (BMI 21.9 + 0.6 kg/m2) and one control 
beverage containing no chlorogenic acid (185g) (BMI 22.0 + 0.5 kg/m2) for 4 
weeks. Energy metabolism was measured using indirect calorimetry pre and post 
intervention and up to 180 minutes postprandial (following a meal). Key findings 
observed following the 4 week intervention were that the beverage containing 
chlorogenic acid showed a significantly higher postprandial energy expenditure, 
especially for fat oxidation 120 minutes after the meal compared to the 
beverage containing no chlorogenic acid (0.958 + 0.0064 vs 0.872 + 0.046 
mg/min/kg), there was no reduction in body weight (kg) or body fat (%). Resting 
fat oxidation rates were measured, however were not reported. Measures of 
blood glucose (mg/dL), were also recorded resulting in a significant reduction in 
fasting plasma glucose levels with the consumption of the cholorogenic acid 
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beverage versus the control following the intervention (99.0 + 2.5 vs 97.8 + 2.2 
mg/dL).  
Additionally, a more recent study by Katada et al, in 2018 investigated the 
effects of a chlorogenic acid enriched (CGA) and hydroxyhydroquinone (HHQ) 
reduced coffee on postprandial fat oxidation and anti-oxidative capacity in 
healthy men. HHQ is an antioxidant component produced during the coffee-bean 
roasting process. Similarly, the study was a randomised, double blind, placebo-
controlled, crossover trial where 15 male volunteer (BMI 22.4 + 1.5 kg/m2) 
consumed either the CGA (382mg) with HHQ or CGA (428mg) without HHQ coffee 
for 4 weeks, it is unclear why the CGA concentration differed between the 
coffee beverages. Postprandial energy metabolism was evaluated 300 minutes 
following a test meal using indirect calorimetry and blood samples were 
collected. Results showed that after the 4 week intervention, postprandial fat 
oxidation (11 + 17 vs 7 + 16 mg/min) and (plasma biological antioxidant potential 
(BAP) and derivatives of reactive oxygen metabolites (d/ROM)) BAP/d-ROMs ratio 
(i.e., less oxidative stress) was significantly higher in the CGA without HHQ 
compared to the CGA with HHQ, there was no significant changes in body mass 
or plasma metabolites such as glucose, insulin and high-density lipoproteins 
cholesterol or low-density lipoprotein cholesterol. It seems that resting fat 
oxidation rates do not increase with cholorgenic enriched coffee however there 
is an increase in postprandial fat oxidation rates, while this was shown in the 
above studies there was no reduction in body fat, a possible reason for this 
discrepancy could be the short intervention period of only 4 weeks and the use 
of normal weight subjects, overweight or obese subjects may have accelerated 
the reduction. 
Regarding the effects of consuming green coffee extract alongside performing 
exercise, the research is somewhat limited. Beam et al, in 2015, investigated 
the effects of post-exercise caffeine and green coffee extract consumption on 
blood glucose and insulin concentration on 10 male cyclists (BMI 24 + 4.3 kg/m2; 
V̇O2peak 55.9 + 8.4 ml/kg/min-1). Following three bouts of 30-minute cycling at 
60% of peak power, subjects consumed 75g of dextrose with either 5 mg/kg body 
weight of caffeine, 10mg/kg of green coffee extract or a placebo, immediately 
after exercise. An oral glucose tolerance test was performed immediately before 
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and after exercise, the results reported no significant difference in blood 
glucose and insulin between the two treatment groups.  
Moreover, Ota et al, 2010 investigated the effect of coffee polyphenols on 
energy metabolism, this was a double blind, placebo-controlled, crossover trial 
involving 7 male subjects, BMI 21.8 + 0.6 kg/m2. Subjects either consumed a 
coffee polyphenol test beverage (chlorogenic acid concentration was 
359mg/185g) or a control beverage containing no polyphenols for 1 week. 
Indirect calorimetry measurements were conducted pre and post intervention 
both after fasting and up to 3.5 hours postprandial, and during exercise. The 
exercise was performed on a cycle ergometer, 20 watt warm up for 3 minutes 
then the work rate was increased 15 watts per minute until 60% of maximal 
heart rate was achieved. They reported the coffee polyphenol beverage led to 
significantly higher oxygen consumption (V̇O2) pre and post meal ingestion and 
during the exercise period, compared to the control beverage. Postprandial V̇O2 
was significantly higher at 30 and 60 minutes after the meal. Furthermore, the 
coffee polyphenol beverage reported a significantly higher fat oxidation rate 90 
minutes after the meal compared to the control beverage. Following the 1 week 
intervention, during exercise, the V̇O2 in the coffee polyphenol beverage group 
was significantly higher in the warm up (20W for 3 minutes) and the first 2 
minutes of the graded exercise session, similarly the anaerobic threshold was 
significantly higher, suggesting the potential to increase endurance capacity. 
There was a trend for fat oxidation during exercise to be higher in the coffee 
polyphenol beverage group, however there was no statistical difference. 
The anti-obesity properties of green coffee extract and chlorogenic acid has 
been linked to the metabolism of glucose (Bassoli et al. 2008; Meng et al. 2013). 
A pilot prospective clinical study in 2007 investigated the effect of a green 
decaffeinated coffee extract (GDCE) on glycaemia, whereby 15 healthy men and 
women consumed 3 capsule/day of GDCE for 40 days with no diet and exercise 
changes. An oral glucose tolerance test was performed before and after the 
supplementation. The results reported significant decreases in post-load 
glycemia (147.8 ± 9.3 vs 133 ± 8.7 mg/dL) compared to pre-load. It was 
concluded that GDCE is able to modulate glucose metabolism (Blum et al. 2007). 
Moreover, a recent study investigated the effects of green coffee extract (GCE  
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400mg 2 x capsules/day) on anthropometric indices, glycaemic control, blood 
pressure and insulin resistance in patients with metabolic syndrome; the 
coexistence of risk factors predisposing to type 2 diabetes and cardiovascular 
disease. Following an 8 week placebo controlled intervention, GCE significantly 
reduced fasting blood glucose (-0.28 ± 3.34 vs 1.63 ± 2.22 mmol/l), waist 
circumference (-2.40 ± 2.54 vs -0.66 ± 1.17 cm) and appetite score (-1.44 ± 1.72 
vs -0.2 ± 1.32). A reduction in body weight was reported significant (-2.08 ± 2.11 
vs -0.95 ± 1.30 kg), however only marginally (p=0.05) (Roshan et al. 2018).   
From the current research, suggestions of proposed mechanisms for these finding 
include that chlorogenic acid inhibits the release of glucose by preventing 
hepatic glucose-6-phosphatase activity and inhibition of glucose absorption in 
the small intestine by preventing glucose-6-phosphatase translocase. This 
limited release of glucose from glycogen through glycogenolysis therefore limits 
the release of glucose into the circulation and thus limits the release of insulin 
into the bloodstream. This, therefore forces lipids to be used as energy to 
compensate for the decrease in glucose and resulting in less fatty deposited in 
the adipose tissue owing to a reduction in insulin therefore inhibiting the fat 
accumulation and resulting in weight loss (as shown in Figure 7). An in vitro 
study in human liver cells investigated the effect of the natural decaffeinated 
green coffee extract ‘Svetol’ and chlorogenic acid on hepatic glucose-6-
phosphatase. It was reported that ‘Svetol’ significantly inhibited glucose-6-
phosphatase in the liver microsomes (Henry-Vitrac et al. 2010). Furthermore, it 
has been discerned that cholorgenic acid could increase adiponectin and 
adiponectin receptors and the phosphorylation of AMP-activated protein kinase 
(AMPK) and reduce the expression of hepatic glucose-6-phosphatase (Naveed et 
al. 2018). AMPK is an enzyme involved in cellular energy homeostasis, largely to 
activate glucose uptake and fatty acid oxidation when cellular energy is low. 
This upsurge in AMPK phosphorylation, adiponectin and adiponectin receptors 
and decrease in glucose-6-phosphatase has been associated with lowered levels 
of triglycerides, fasting glucose and cholesterol, inhibits fatty liver and an 
upsurge of glucose tolerance and insulin sensitivity is also observed (Naveed et 
al. 2018).  
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Figure 7. Chlorogenic acid; how does it work (Adapted from www.vitalhealth.com) (Naveed 
et al. 2018). 
 
While the results from these trials are promising, the mechanisms of action on 
glucose and lipid metabolism have not yet been conclusively elucidate, 
therefore more research is needed to confirm these claims and potential 
mechanisms of action. 
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1.4 Study Aim 
Raspberry ketone and green coffee bean extract are both marketed to have 
beneficial effects on weight loss and are often sold in a combined capsule form. 
Research on these supplements seems to be limited and their possible 
mechanisms of action remains unclear. The aim of the present study is to test 
whether these commonly used dietary food supplements have any effect on fat 
oxidation and body composition when consumed individually and in combination.  
It was hypothesized that raspberry ketone and green coffee bean extract, either 
alone and/or in combination would reduce body mass and fat mass and increase 
the rate of fat oxidation at rest and during exercise. 
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2 Methods 
2.1 Subject Recruitment and Screening 
A total of 39 recreationally active (≤ 3 exercise sessions per week) males and 
females between the age of 18 and 45 years were recruited to participate in the 
study. Subjects were required to have a body mass index (BMI) greater than or 
equal to 23 kg/m2 and be non-smoking. Subjects were excluded if they had any 
previous history of a metabolic disorder or cardiovascular disease or were taking 
medications that may alter insulin sensitivity or antihypertensive drugs. Subjects 
were also excluded if they were currently following a diet plan or training for a 
sporting event, they were asked to complete an activity questionnaire (See 
appendix A). Subjects were recruited from the student and staff population of 
University of Glasgow via local advertising. 
Subjects attended a screening visit at the university prior to participation, to 
ensure they met with the criteria for inclusion in the study. A health 
questionnaire detailing the subject’s past, present health status and family 
history of disease were completed (see appendix A). Resting blood pressure was 
measured using an automated sphygmomanometer (Boso Medicus, Germany) and 
height and weight were measured to ensure BMI was in the appropriate range. 
They were provided with an information sheet describing the aim of the study, 
the experimental procedures involved and any potential risks or discomfort 
associated with these procedures which were also verbally explained to them. 
The study was approved by the MVLS ethics committee and written, informed 
consent was recorded for each subject. 
2.2 Experimental Design 
This study was a randomised, placebo-controlled, single blind design. The 
researcher was blinded to the randomisation of the study and the subjects were 
not told what treatment they were getting, however due to the distinct taste of 
some of the supplements they may have been able to distinguish which 
supplement they were allocated. The study intervention involved 8-weeks 
supplementation with a randomly assigned dietary food supplement. This was 
either a placebo, raspberry ketone, green coffee bean extract or a combination 
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of both raspberry ketone plus green coffee bean extract supplement (two 
capsules with a meal per day). Subjects were asked to attend the laboratory on 
three separate occasions; two baseline measurement visits and one post 
supplementation visit. For the duration of intervention subjects were asked to 
maintain their habitual dietary and physical activity regime 
 
Figure 8. Experimental design – Visit 1 and 2 followed by the 8 week treatment intervention, 
then visit 3. 
 
2.2.1 Food Diary 
One week prior to starting the study, subjects completed a 7 day food diary. 
This was used to record habitual food intake, using a nutritional analysis 
program (WISP 4.0) and the last 3 days from the 7 day food dairy was repeated 
prior to future study visits.  
2.2.2 Accelerometer 
Subjects wore an activPAL accelerometer (activPAL 3c, PAL Technologies Ltd, 
Glasgow, UK) for a 7 day period during the first week of the intervention. This 
monitor was worn on the right thigh, 10cm above the knee during waking hours 
and removed for showering or bathing. This was used to quantify habitual 
physical activity and sedentary behaviour levels. 
  
- Food Diary 
- Accelerometer 
 
- Visit 1 
- Visit 2 
- Visit 3 
7 days 48 hours 8 Week Treatment Intervention 
45 
 
2.2.3 Baseline Measurements – Visit 1 
Subjects arrived in the laboratory in the morning following a 12-hour overnight 
fast, they were asked to refrain from strenuous exercise 24 hours prior to this 
visit. Firstly a measure of resting metabolic rate (RMR) was performed followed 
by the anthropometric measures of height, body mass, circumference 
measurements and body composition. Finally a maximal incremental exercise 
test was performed on a cycle ergometer to measure maximum oxygen uptake 
(V̇O2max). 
2.2.4 Baseline Measurements – Visit 2 
On a separate visit to the laboratory, at least 48 hours after visit 1, subjects 
arrived in the laboratory in the morning following a 12-hour overnight fast, they 
were asked to refrain from strenuous exercise 24 hours prior to this visit. A 30 
minute steady state exercise test was performed on a cycle ergometer at a work 
rate estimated to elicit 55% V̇O2max. Expired air and heart rate was measured and 
a blood sample was taken at 10 minute intervals throughout the test. 
2.2.5 Intervention Treatment 
Following the baseline measurements subjects were randomly assigned to one of 
the following supplements for an 8 week period: placebo (maltodextrose sugar – 
400mg/day), green coffee bean extract (400mg/day) (standardised to contain 
50% Chlorogenic Acids, 200mg), raspberry ketones (200mg/day) and combined 
green coffee bean extract (standardised to contain 50% Chlorogenic Acids, 
200mg)/raspberry ketones (200mg/day and 400mg/day respectively) (see figure 
9).  
From doing some initial research into the recommended concentrations of the 
supplements it seemed that there was not much variation regarding green coffee 
bean extract and 400mg was a commonly used concentration. This is the 
concentration used in the market branded variety of green coffee bean extract, 
‘coffee slender’ and ‘svetol’. However, raspberry ketone concentrations in 
supplements seemed to vary from 100-500mg and with no other clinical trials to 
compare against a small pilot study (n=5) was carried out prior to the current 
study looking at the different concentration of raspberry ketone. Resting 
46 
 
metabolic rate was recorded at baseline following a 12 hour fast then repeated 
after 7 days on 3 different concentrations of raspberry ketone (100, 250 and 
500mg – consuming 2 capsules per day or as instructed on the packaging), with a 
7 day wash out period between supplements. It was concluded from this that 
there was no dose-response relationship, therefore 100mg (100mg x 2 per/day) 
was chosen as the investigative concentration for this study. 
Two capsules of each supplement were taken daily alongside a meal. All 
supplements were purchased from well-known commercially available health 
food chains. The randomisation was performed by a colleague uninvolved in the 
research using a randomised computer program. During the intervention the 
researcher kept in regular contact (every 2 weeks throughout the 8 weeks) with 
the participant to check with their compliance to taking the supplement, 
maintaining their regular lifestyle and any illnesses (See Appendix B).  
 
 
Figure 9. Intervention treatment. Subjects were assigned to either a placebo, raspberry 
ketone, green coffee bean extract or a combination of both raspberry ketone plus raspberry 
ketone supplement (two capsules with a meal per day) for 8 weeks. 
 
Treatment 
Combined green 
coffee bean/ 
raspberry ketone 
(400mg/day & 
200mg/day) 
(400mg/day & 
Raspberry ketone 
(200mg/day) 
Green coffee  
bean extract  
(50% Chlorogenic 
acid; 400mg/day) 
Placebo  
(Maltodextrose 
sugar 400mg/day) 
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2.2.6 Post Intervention – Visit 3 
Following the 8-week intervention subjects arrived in the laboratory in the 
morning following a 12-hour overnight fast, having taken their last supplement 
with their last meal, they were also asked to refrain from strenuous exercise 24 
hours prior to this visit. Prior to this visit subjects repeated the last 3 days from 
their 7 day food dairy. Post measurements of RMR, anthropometric measures and 
a steady state exercise test were repeated. 
2.3 Experimental Measurements 
2.3.1 Anthropometric Measurements 
Anthropometric measurements were recorded pre and post intervention. 
2.3.1.1 Height  
Height was measured using the stretch stature method on a stadiometer (Seca, 
Hamburg, Germany). Measurement was recorded to the nearest 0.1 cm. Stature 
was recorded as the maximum distance from the floor to the highest point of the 
skull when the head is held in the Frankfort plane position following a full 
inspiration (Ross and Marfell-Jones 1991).  
2.3.1.2 Body Mass  
Body mass was measured in minimal clothing and without shoes to the nearest 
0.01 kg. Body mass was measured using the same balanced scale for both pre 
and post measurements. BMI was calculated as weight in kilograms divided by 
the square of height in metres. 
2.3.1.3 Circumference Measurements 
Waist and hip circumference were measured in contact with the skin using a 
flexible, steel tape measure (Lufkin Executive thin line 2M, Mexico). Waist 
circumference was taken with subjects standing with feet shoulder-width apart 
and arms folded across the thorax and landmarked as the narrowest part of the 
torso, mid-way between the inferior margin of lowest rib and the iliac crest with 
the abdominal muscles relaxed. Hip circumference was taken with the subjects 
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standing with feet together and arms folded across the thorax and landmarked 
as the maximum circumference over the trochanters (buttocks) (Lean et al. 
1995). With respect to both landmarks, the tape was placed horizontally directly 
on the skin. All measurements were taken at the end of a normal expiration, 
with repeated measurement. If the two measurements disagreed by more than 
0.1 cm; a third measurement was made. 
2.3.1.4 Body Composition 
The BOD POD is an Air Displacement Plethysmograph (ADP) that uses whole body 
densitometry to determine body composition (fat vs. lean tissue). The BOD POD 
measures body mass (weight) using scales, and volume by sitting inside the BOD 
POD. Body density is then calculated; Density = Mass/Volume. Once the overall 
density of the body was determined, the relative proportions of body fat and 
lean body mass were calculated using the Siri equation (% Body Fat = (495/Body 
density) - 450). Prior to each measurement, the BOD POD was calibrated with a 
known volume cylinder. Participant were advised to wear minimal tight fitting 
clothing and remove any jewellery to minimise any errors. 
2.3.2 Expired Air Measurements 
2.3.2.1 Resting Metabolic Rate 
Resting metabolic rate (RMR) was measured pre and post intervention using an 
open circuit indirect calorimetry system with a ventilated hood (Quark CPED, 
Cosmed, Italy). The apparatus included a high-speed differential paramagnetic 
O2 sensor and a nondispersive infrared sensor (NDIR) for CO2 analysis. Before 
each test, the gas analyser was calibrated using an automated calibration 
procedure, whereby a calibration gas mixture (16% O2, 5% CO2) was introduced 
to the system. A turbine flow-meter calibration was also performed using a 
calibrated 3-liter syringe where by a series of ten complete pumps of the syringe 
was repeated until the values were within the acceptability range. Weekly 
alcohol-burning tests were conducted on the system for validation purposes. 
For RMR determination, subjects arrived in the laboratory in the morning 
following a 12-hour overnight fast. The last 3 days of their recorded 7-day food 
dairy was following prior to each measurement. Before the start of each 
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measurement, each subject was asked to lie quietly in a semi-recumbent 
position for 10 min in a temperature-controlled (21°C – 23 °C) environment. 
Next, a transparent ventilated plastic hood connected to the gas mixing chamber 
by corrugated flexible plastic tubing was placed over the subject’s head. Rates 
of oxygen consumption (V̇O2) and carbon dioxide production (V̇CO2) were 
continuously measured then averaged for each 1 minute interval. The 
measurement was performed for 25 minutes and data from the last 15 minutes 
were averaged to determine RMR. Resting rates of fat and carbohydrate (g/min-
1) were also recorded. 
 
 
Figure 10. Resting metabolic rate. Substrate utilisation measurement using an open-circuit 
indirect calorimetry system with a ventilated hood. 
 
2.3.2.2 Measurements of Expired Air during Exercise 
During exercise expired air was collected using the Douglas bag method, which 
involves the collection of exhaled air in large, impermeable 150 litre bags and 
measurements of gas fractions and expired volumes were obtained. The bags 
were completely emptied using an exhaust pump prior to usage. Participants 
were fitted with a rubber mouthpiece and breathed ambient air through a two-
way non-rebreathing valve (Kansas City, MO) which was connected to a 
previously evacuated 150-liter Douglas bag (Hans Rudolph P/N 112377, Hans 
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Rudolph Inc., Kansas City, USA) on the expired side by a 1 m corrugated flexible 
plastic hose of a 3.2 cm diameter. A nose clip was worn to prevent nasal 
breathing. To determine fractions of O2 and CO2 in the bag, after gas collection, 
a small quantity of air was extracted from the used Douglas bag at a constant 
flow rate (500 ml/min-1), measured by a flow meter and then passed into a gas 
analyser (Servomex, Sussex, UK). The analyser was calibrated prior to each test 
using certified reference gases (BOC Gases, Surrey, UK) of known concentration 
(e.g. 100% nitrogen, 18% O2, 3% CO2). The remaining volume of air in the used 
Douglas bag was vacuumed out using a dry gas meter (Harvard Apparatus, Kent, 
UK) and expired air volumes and temperature were recorded. To determine V̇O2 
(STPD), V̇CO2 (STPD), and respiratory exchange ratio (RER), expired gas fractions 
and volumes were then corrected for standard temperature (ºC) and barometric 
pressure at sea level (760 mmHg). RER was calculated as V̇CO2 divided by V̇O2. 
2.3.2.3 Expired Air Analysis 
According to stoichiometric equations of Frayn, (1983), calculation of fat and 
carbohydrate oxidation rates, and energy expenditure were estimated from V̇O2 
(STPD) and V̇CO2 (STPD). According to the formula, O2 uptake and CO2 
production can be assumed as: 
V̇O2 (l/min-1) = 0.746 c + 2.03 f + 6.04 n 
V̇CO2 (l/min-1) = 0.746 c + 1.43 f + 4.89 n  
Where; c = carbohydrate oxidation in grams per minute, f = fat oxidation in 
grams per minute, n = urinary nitrogen excreted in grams per minute. 
For carbohydrate oxidation, a V̇O2 of 0.746 litres is associated with glucose 
oxidation but increases to 0.829 litres if glycogen is preferentially oxidised. 
Using equations based on glycogen as a fuel source in a situation where glucose 
oxidation predominates may lead to a substantial underestimation of 
carbohydrate oxidation (Jequier et al. 1987). Assuming that there is an absence 
of net lipogenesis, gluconeogenesis, or ketogenesis or any acid-base 
disturbances, these equations were derived. The equations were then solved for 
c grams of carbohydrate and f grams of fat oxidised per minute: 
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f (g/min-1) = 1.67 V̇O2 – 1.67 V̇CO2 – 1.92 n  
c (g/min-1) = 4.55 V̇CO2 – 3.21 V̇O2 – 2.87 n  
Based on data from similar studies in the literature, nitrogen excretion rate was 
assumed at 0.00011 g/kg−1/min−1 throughout all tests (Melanson et al. 2005; 
Flatt et al. 1985).  
Energy expenditure (EE), was calculated as the sum of each macronutrient 
oxidation rate (g/min-1) multiplied by the appropriate conversion factor (glucose 
= 3.7 kcal/g-1; fat = 9.3 kcal/g-1) and expressed in kcal/min-1 then converted into 
kilojoules (Kj/min-1 and kj/day-1), where 1 kcal is equal to 4.184 kj (Livesey and 
Elia, 1998). 
EE (kcal/min-1) = f (g/min-1) x 9.3 + c (g/min-1) x 3.7 
2.4 Exericse Testing 
2.4.1.1 Maximal Exercise Test 
A maximal incremental exercise test was performed on an electronically braked 
cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands) to calculate 
maximum oxygen consumption (V̇O2max) and maximum power (Wmax), this was 
performed for each subject to calculate the work rate required for the steady 
state exercise test. 50% of Wmax is equal to 55% V̇O2max (Hodgson et al. 2013). 
A 5 minute warm up at 20 watts was firstly performed on the cycle ergometer, 
following this the work rate was increased in steps of between 15-25 watts per 
minutes until volitional exhaustion (15 watts for females and 25 watts for 
males), the test was terminated when the subject was unable to maintain a 
revolution per minute (rpm) of greater than 50 rpm. Expired air was collected 
using the Douglas bag method during the last stages of the test in 1 minute 
intervals. Heart rate was continuously monitored throughout the test and the 
maximum heart rate at the end of the test was recorded.  
Attainment of true V̇O2max was achieved if 3 out of 4 of the essential criterial 
were met (Duncan et al. 1997): maximum heart rate within 10 bpm of the 
52 
 
predicted maximum heart rate (using the predicated maximum heart rate 
(HRmax) equation of 220-age), plateau in V̇O2 (change < 2.1 ml/kg-1/min-1), RER 
of 1.1 and blood lactate level of >8mmol-1. Blood lactate was not measured post 
exercise, therefore the other 3 criteria were observed to confirm attainment of 
true V̇O2max. 
2.4.1.2 Steady State Exercise Test 
A 30 minute steady state exercise test was performed on an electronically 
braked cycle ergometer with the work rate set at approximately 55% V̇O2max pre 
and post intervention. Before the start of the test a cannula was inserted into an 
antecubital or forearm vein and following a 10 minute rest period a 10ml blood 
sample was taken into an EDTA tube. Further blood samples were taken at 10 
minute intervals throughout the 30 minute test to assess for metabolic markers. 
The cannula was flushed with saline solution after each sample and a total of 
40mls of blood was taken during each test. 
Expired air and heart rate were measured at 10 minute intervals throughout the 
test before the blood sample was taken. V̇O2 (l/min-1), V̇CO2 (l/min-1) and rates 
of fat and carbohydrate (g/min-1) were calculated. An additional expired air 
sample was collected during minutes 3-4 of the test, V̇O2 (l/min-1) was 
calculated to ensure the work rate was approximately set to 55% V̇O2max, the 
work rate was then adjusted accordingly if required. 
 
Figure 11. 30 minute steady state exercise test (55% V̇O2max). 
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2.4.1.3 Heart Rate Monitoring 
Heart rate during exercise was monitored using a Polar® heart rate telemetry 
system which consisted of a heart rate transmitter and a wrist receiver (POLAR, 
Kempele, Finland) during the maximal exercise test and 30 minute steady state 
exercise test. Heart rate was continuously monitored during the maximal 
exercise test and obtained at 10 minutes intervals during the 30 minute steady 
state exercise test, averaged over the last minute of each interval. 
2.4.1.4 Blood Analysis 
Following collection, all blood samples were rested upon ice until the end of the 
experimental trial. Following this each tube was centrifuged at 4000 rpm for 15 
minutes at 4 ºC (Hettich Universal 320R Centrifuge, Germany). The plasma was 
aliquot into Eppendorf tubes then frozen at -80 ºC for later analysis. Each blood 
sample taken throughout each experimental trial was analysed for plasma 
glucose and lactate. 
Plasma glucose and lactate were analysed using a glucose & L-Lactate analyser 
(YSI 2300 STAT PLUS, USA). The analyser was calibrated using a glucose standard 
of 10.0 mmol/l and a lactate standard of 5.00 mmol/l. A self-calibration is 
performed every 5 samples or 15 minutes, if a difference of more than 2% 
between the present and previous net calibration occurred the calibration was 
repeated. In run mode the sipper pump piston retracts and draws in 25 
microliters of sample, all samples were analysed in duplicate or until a 
difference of <0.02 mmol/l was determined. 
2.4.2 Statistical Analysis 
Statistical analyses were performed using SPSS (IBM SPSS Statistics 24, 2016). 
Where only baseline data was collected (e.g. physical activity and dietary data) 
differences between groups were compared via a one-way ANOVA. All other data 
were compared with a two-way (time and supplement) repeated measures 
ANOVA. Data are presented as mean SEM and significant differences were 
accepted at p<0.05.  
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The current study was a pilot study and so the sample size had been calculated 
to detect changes in body mass (primary outcome) within each group but not to 
detect differences in changes between groups, (i.e. an interaction effect). Based 
on previous work with supplements containing raspberry ketones, which 
demonstrated a 2 ± 2 kg decrease in body mass (Lopez et al. 2013), we will 
require 10 participants per group to detect a similar change with 80% power at 
P<0.05. To allow for dropout we will recruit 12 participants to each group. 
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3 Results 
3.1 Participants 
All participants were recreationally active males and females between the age 
of 18 and 45 years, non-smoking and had a BMI > 23 kg/m2. Of the 39 
participants initially recruited, 7 were lost due to poor compliance to the 
treatment [n=3], illness [n=1] and with no reason given [n=3]. Of the 32 subjects 
who completed the study there were 21 females and 11 males. Subject 
demographics were similar between treatment groups (all p>0.05); Raspberry 
Ketone (RK), Green Coffee Extract (GCE), Raspberry Ketone + Green Coffee 
Extract (RK+GCE) and Control Groups (Control). The ANOVA revealed no 
significant difference between the groups for Age (p=0.115), Height (p=0.531), 
Body mass (p=0.533), BMI (p=0.801) and V̇O2max (p=0.811). 
Table 1. Descriptive characteristics of the 32 recruited subjects and the 4 treatment groups. 
Total of 11 males & 21 females (n=32). RK group: 5 males & 3 females (n=8); GCE group: 3 males 
& 5 females (n=8); RK+GCE group: 1 male & 7 females (n=8); Control group: 2 males & 6 females 
(n=8). Values are means ± S.E.M. 
 
3.2 Dietary Intake and Physical Activity 
All participants wore an activPAL accelerometer for 7 days, and there was no 
difference in total physical activity between the groups (EE 
(MET/H/Week)p=0.762) (Table 2). One week prior to starting the study, subjects 
completed a 7 day food dairy.  
Variable 
 
Total 
(n=32) 
RK 
(n=8) 
GCE 
(n=8) 
RK+GCE 
(n=8) 
Control 
(n=8) 
 
Age (years) 
 
 
30.4 ± 1.5 
 
34.6 ± 2.9 
 
24.8 ± 2.2 
 
30.0 ± 3.2 
 
32.2 ± 3.1 
 
Height (cm) 
 
 
171.8 ± 1.7 
 
175.2 ± 3.4 
 
172.6 ± 3.7 
 
168.2 ± 3.0 
 
171.1 ± 
3.4 
 
Body Mass (kg) 
 
 
79.0 ± 1.8 
 
82.5 ± 3.8 
 
81.1 ± 3.0 
 
75.9 ± 3.8 
 
76.7 ± 4.1 
 
BMI (kg/m2) 
 
 
26.7 ± 0.4 
 
26.8 ± 0.8 
 
27.2 ± 0.8 
 
26.8 ± 1.0 
 
26.2 ± 0.7 
 
V̇O2max (ml/kg/min)
-1 
 
 
37.7 ± 1.4 
 
39.2 ± 2.1 
 
38.9 ± 2.9 
 
35.8 ± 3.5 
 
36.8 ± 2.9 
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For Energy Intake (EI) the ANOVA revealed no significant differences between 
the groups (p=0.825). Similarly there was no difference between all the dietary 
variables, Fat (p=0.866), CHO (p=0.580), Protein (p=0.596) and Alcohol 
(p=0.721). 
Table 2. Total physical activity (MET/h/week) from 7 day accelerometer. Average EI (KJ), fat 
(g/day), CHO (g/day), protein (g/day) and alcohol (g/day) from 7 day food diaries.                                  
Values are means ± S.E.M. 
 
3.3 Anthropometric Measurements & Resting Metabolism 
3.3.1 Anthropometric Measurements 
The baseline and post-intervention anthropometric are presented in Table 3. For 
body weight the ANOVA revealed a significant effect of time (p=0.004), but no 
supplement (p=0.528) or interaction effects (p=0.548) were noted. For body fat 
no time (p=0.942), supplement (p=0.461) or interaction effects (p=0.933) were 
observed. Waist circumference revealed a significant effect of time (p=0.043), 
but no supplement (p=0.450) or interaction effects (p=0.503) were noted. For 
hip circumference no time (p=0.082), supplement (p=0.961) or interaction 
effects (p=0.912) were seen.   
Variable 
 
RK GCE RK+GCE Control 
 
EE (MET/H/Week) 
 
 
238.8 ± 16.1 
 
228.0 ± 5.2 
 
226.1 ± 5.7 
 
231.8 ± 5.7 
 
EI (KJ) 
 
 
8314.9 ± 914.2 
 
9093.7 ± 784.4 
 
7733.7 ± 656.0 
 
8576.9 ± 1460.2 
 
Fat (g/day) 
 
 
73.5 ± 15.2 
 
83.9 ± 5.6 
 
76.4 ± 8.6 
 
84.3 ± 12.8 
 
CHO (g/day) 
 
 
244.3 ± 26.5 
 
261.8 ± 29.9 
 
207.7 ± 15.0 
 
221.5 ± 38.8 
 
Protein (g/day) 
 
 
73.8 ± 6.2 
 
81.7 ± 8.1 
 
75.2 ± 12.7 
 
100.7 ± 25.4 
 
Alcohol (g/day) 
 
 
9.6 ± 3.3 
 
4.8 ± 2.0 
 
11.0 ± 5.2 
 
9.3 ± 5.0 
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Table 3. Anthropometric variables of treatment groups. Values are means ± 
S.E.M.
  
3.3.2 Resting Metabolism 
For resting fat oxidation rates the ANOVA revealed no significant effects of time 
(p=0.992) and no supplement (p=0.809) or interaction (p=0.293) effects were 
observed. Similarly, for resting carbohydrate (CHO) oxidation rates no time 
(p=0.874), supplement (p=0.978) or interaction (p=0.348) effects were seen. 
For resting energy expenditure the ANOVA revealed no significant effects of time 
(p=0.847) and no supplement (p=0.798) or interaction (p=0.579) effects were 
observed. Similarly, energy expenditure during exercise no time (p=0.703), 
supplement (p=0.342) or interaction (p=0.582) effects were seen. 
 
 
 
 
 
 
 
Variable RK GCE RK+GCE Control 
 Pre Post Pre Post Pre Post Pre Post 
 
Body Mass 
(kg) 
 
 
82.5 ± 
3.8 
 
81.6 ± 
3.9 
 
81.1 ± 
3.0 
 
81.0 ± 
3.2 
 
75.9 ± 
3.8 
 
74.5 ± 
4.0 
 
76.7 ± 
4.1 
 
76.3 ± 
4.2 
 
Body Fat 
(%) 
 
 
25.6 ± 
3.3 
 
25.9 ± 
2.7 
 
28.2 ± 
4.3 
 
28.7 ± 
4.2 
 
33.0 ± 
3.8 
 
32.4 ± 
3.7 
 
25.8 ± 
3.6 
 
25.8 ± 
3.3 
 
Waist 
(cm) 
 
 
87.3 ± 
2.9 
 
86.4 ± 
2.7 
 
83.8 ± 
2.2 
 
83.8 ± 
2.1 
 
83.6 ± 
2.3 
 
82.1 ± 
2.1 
 
81.0 ± 
2.6 
 
80.5 ± 
2.7 
 
Hip (cm) 
 
 
 
105.4 ± 
2.8 
 
105.1 ± 
2.7 
 
106.9 ± 
1.5 
 
106.4 ± 
1.7 
 
106.2 ± 
3.7 
 
105.6 ± 
3.9 
 
104.9 ± 
2.0 
 
104.8 ± 
2.0 
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Table 4. Mean Fat & CHO oxidation rates (g/min) during rest and exercise and mean energy 
expenditure (EE) at rest (kj/min) and during exercise (kj/min).                                             
Values are means ± S.E.M. 
 
3.4 Exercise 
3.4.1 Fat and Carbohydrate Oxidation 
For fat oxidation rates during the steady state exercise test, the ANOVA revealed 
no significant effects of time (p=0.368) or supplement (p=0.396) and no 
interaction (p=0.621) effects were seen. Similarly, for carbohydrate (CHO) 
oxidation rates during exercise no time (p=0.318), supplement (p=0.067) or 
interaction (p=0.712) effects were observed (Table 4). 
 
 
Variable RK GCE         RK+GCE         Control 
 Pre Post Pre Post Pre Post Pre Post 
Fat 
Oxidation 
(g/min) 
(Resting) 
 
 
0.07 ± 
0.01 
 
0.06 ± 
0.01 
 
0.06 ± 
0.01 
 
0.07 ± 
0.00 
 
0.05 ± 
0.01 
 
0.07 ± 
0.01 
 
0.07 ± 
0.01 
 
0.06 ± 
0.00 
CHO 
Oxidation 
(g/min) 
(Resting) 
 
 
0.11 ± 
0.02 
 
0.12 ± 
0.01 
 
0.11 ± 
0.02 
 
0.11 ± 
0.02 
 
0.13 ± 
0.03 
 
0.10 ± 
0.02 
 
0.10 ± 
0.02 
 
0.12 ± 
0.01 
Fat 
Oxidation 
(g/min) 
(Exercise) 
 
 
0.35 ± 
0.03 
 
0.41 ± 
0.04 
 
0.33 ± 
0.05 
 
0.34 ± 
0.04 
 
0.40 ± 
0.03 
 
0.45 ± 
0.04 
 
0.41 ± 
0.06 
 
0.38 ± 
0.05 
CHO 
Oxidation 
(g/min) 
(Exercise) 
 
 
1.53 ± 
0.20 
 
1.37 ± 
0.22 
 
1.61 ± 
0.25 
 
1.60 ± 
0.21 
 
0.97 ± 
0.14 
 
0.90 ± 
0.14 
 
1.17 ± 
0.23 
 
1.21 ± 
0.22 
Energy 
Expenditure 
(Kj/min) 
(Resting) 
 
 
16.3 
 ± 1.0 
 
15.8 
 ± 0.9 
 
 
15.1 
 ± 1.0 
 
 
15.7 
 ± 1.2 
 
 
14.7 
 ± 0.8 
 
 
14.9 
 ± 1.2 
 
 
14.9 
 ± 1.0 
 
 
14.9 
 ± 0.9 
 
Energy 
Expenditure 
(Kj/min) 
(Exercise) 
 
 
37.3 ± 
3.3 
 
37.3 ± 
2.7 
 
38.0 ± 
3.5 
 
38.2 ± 
3.8 
 
30.8 ± 
3.1 
 
31.8 ± 
3.0 
 
34.1 ± 
3.8 
 
33.8 ± 
4.0 
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Figure 12. Fat oxidation rates (g/min) during 30 minute steady state exercise, pre (black 
circle) and post (white circle) intervention. Raspberry ketone (RK), Green coffee bean 
extract (GCE), Raspberry ketone + green coffee bean extract (RK + GCE) and Control. Values 
are means ± S.E.M. 
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Figure 13. Carbohydrate (CHO) oxidation rates (g/min) during 30 minute steady state 
exercise, pre (black circle) and post (white circle) intervention. Raspberry ketone (RK), 
Green coffee bean extract (GCE), Raspberry ketone + green coffee bean extract (RK + GCE) 
and Control. Values are means ± S.E.M. 
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3.4.2 Steady State Exercise Test 
Participants completed the steady state exercise test at a similar (p=0.431) 
workload, heard rate and % of V̇O2max between the groups (Table 5). 
Table 5. Treatment groups work rate (Watts), % V̇O2max (ml/kg/min) & HR (bpm) during 30 
minute steady state exercise test, pre & post intervention.                                                                                                                   
Values are means ± S.E.M 
 
 
3.4.3 Plasma Metabolite Concentrations 
Plasma metabolite responses at rest and exercise are displayed in figure 3 and 4. 
For plasma glucose concentrations (Figure 3) the ANOVA revealed no significant 
time (p=0.433), supplement (p=0.726) or interaction (p=0.905) effects. Similarly, 
for plasma lactate concentrations (Figure 4) during exercise reported, no time 
(p=0.259), supplement (p=0.943) or interaction (p=0.763) effects were observed. 
 
Variable RK GCE RK+GCE Control 
 Pre Post Pre Post Pre Post Pre Post 
 
Work rate 
(Watts) 
 
 
 
108 ± 
10.6 
 
108 ± 
10.6 
 
107 ± 
12.1 
 
107 ± 
12.1 
 
88 ± 
11.5 
 
88 ± 
11.5 
 
97 ± 
13.4 
 
97 ± 
13.4 
 
% V̇O2max 
(ml/kg/min) 
 
 
 
56 ± 1.9 
 
57 ± 1.5 
 
59 ± 0.9 
 
59 ± 1.4 
 
57 ± 0.8 
 
59 ± 1.4 
 
59 ± 1.2 
 
59 ± 2.0 
 
HR (bpm) 
 
 
 
 
127 ± 
4.0 
 
128 ± 
5.3 
 
136 ± 
4.9 
 
145 ± 
5.3 
 
129 ± 
5.2 
 
136 ± 
5.7 
 
119 ± 
4.2 
 
124 ± 
5.0 
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Figure 14. Plasma glucose concentrations (mmol/L) during 30 minute steady state exercise, 
pre (black circle) and post (white circle) intervention. Raspberry ketone (RK), Green coffee 
bean extract (GCE), Raspberry ketone + green coffee bean extract (RK + GCE) and Control. 
Values are means + S.E.M. 
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Figure 15. Plasma lactate concentrations (mmol/L) during 30 minute steady state exercise, 
pre (black circle) and post (white circle) intervention. Raspberry ketone (RK), Green coffee 
bean extract (GCE), Raspberry ketone + green coffee bean extract (RK + GCE) and Control. 
Values are means + S.E.M. 
 
On completion of the 8 week intervention, participants were asked if they had 
experienced any adverse side effects, for example; reduced appetite, nausea, 
normal sleeping pattern, illness and general wellbeing. No adverse side effects 
were reported (See Appendix B). 
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4 Discussion 
Despite the increasing popularity for the use of food supplements as an aid for 
weight loss, there is very limited clinical evidence to support such claims. The 
aim of the study was to determine whether commonly used dietary food 
supplements; Raspberry Ketone and Green Coffee bean extract, have any effects 
on substrate utilisation and body composition when consumed either individually 
or in combination following an 8 week treatment period. The current study 
found that following an 8 week treatment intervention, there was no significant 
effect of either supplement alone, or in combination on body mass (kg) or body 
fat (%). Similarly, there were no differences in substrate utilisation at rest or 
during exercise following the intervention. These results go against our 
hypothesis that these commonly used dietary food supplements would increase 
fat oxidation resulting in a possible weight loss. 
4.1 Effects of Green Coffee Bean Extract 
Very few studies have examined the effects of raspberry ketone on body weight, 
whilst there is some supporting evidence for green coffee bean extract to have a 
weight loss effect, studies do report conflicting observations. The present study 
involved 32 subjects and investigated 4 treatment groups; RK, GCE, RK+GCE and 
a control group, the participants were recreationally active and all had a BMI 
>23 kg/m2, the findings reveal that for all treatment groups there was no effect 
of the supplements on body mass (kg). In comparing these finding to the 
literature, studies by Thom in 2007 and Dellalibera et al. 2006 both reported 
reductions in body mass following an intervention of consuming either ‘Coffee 
Slender’ or ‘Svetol’, both chlorogenic acid enriched coffee beverages, at similar 
concentration to the green coffee bean extract used in the current study. The 
main difference between these studies and the current work is that they studied 
overweight/obese individuals, BMI 25-32 kg/m2, whilst the present study 
involved individuals with a BMI >23 kg/m2 (mean BMI = 26.7 + 0.4 kg/m2). Thom, 
2007 investigated 30 overweight individual with BMI between 27.5-32 kg/m2 with 
the average being 29 kg/m2 following a 12 week intervention. In 2006, 
Dellalibera et al, studied 50 overweight individuals with BMI>25 kg/m2, however 
the baseline average BMI was not reported. They reported a significant reduction 
in body weight in the ‘Svetol’ group compared to the control, 4.97 + 0.32 kg 
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(5.7%) versus 2.45 + 0.37 kg (2.9%) following an intervention of 60 days, 
moreover this study was not part of a weight loss programme, however the 
control group reported a 2.45kg reduction in body weight, and they did not give 
a possible explanation to account for this. 
In a systematic review and meta-analysis of randomised control trials on the use 
of green coffee bean extract, it was reported that the studies above (Thom 2007 
and Dellalibera et al. 2006) have been identified as having poor methodological 
quality with significant heterogeneity amongst the studies, for example small 
sample size and short-term supplement duration and limited descriptive 
information on the participants (Onakpoya et al. 2011; (Hausenblas and Huynh, 
2014). The authors reported there was a high risk of bias, both papers were not 
clear on their blinding method or how the randomisation was carried out and 
there was no information on blinding of outcome assessors, the internal validity 
of these trials may prove doubtful. Dellalibera et al, also has two authors 
affiliated to the company which marketed ‘Svetol’, they did not declare any 
conflicts of interest and also did not state if the green coffee extract use in the 
‘Svetol’ capsule was fortified with chlorogenic acid and if so what percentage 
was used. As well as that, the papers provided very little information regarding 
the baseline characteristic of their participants, such as weight or BMI. Despite 
stating that an objective of the study was to investigate if ‘Svetol’ could limit 
overweight, obesity development and secondary diseases associated, the author 
did not discuss any end point or results relating to these issues (Buchanan and 
Beckett, 2013). Thom et al, seemed to compare the resulting mean values with 
baseline data for each group individually, rather than directly comparing mean 
weight and BMI between the groups following the 12 weeks of treatment. Also, 
the title of the study suggests they are investigating the ‘long term’ effect of 
‘Coffee Slender’ on body mass, however the intervention was only for 12 weeks, 
providing no information regarding the long-term efficacy or safety (Buchanan 
and Beckett, 2013). 
On the other hand, as detailed above the present study investigated individuals 
with a BMI >23 kg/m2, with the average BMI = 26.7 + 0.4 kg/m2 (n=32), thus 
lower than the aforementioned studies, it could indicate that green coffee bean 
extract may be more effective in overweight or obese individuals with a higher 
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BMI in reducing body mass. But with this issue with the previous studies detailed 
above, this is far from certain. Studies carried out on normal weight individuals 
(BMI <25 kg/m2) have investigated the effects of green coffee extract on people 
with hypertension and reported no effects on BMI (Watanabe et al. 2006; 
(Kozuma et al. 2005). This was confirmed by the results of a recent systematic 
review and meta-analysis in 2014, who concluded green coffee bean extract 
supplementation resulted in significant weight loss for overweight/obese 
individuals but not for normal weight individuals with mild hypertension 
(Hausenblas and Huynh, 2014). 
Similar findings to the current were reported by Soga et al, in 2013, who 
investigated the effects of consumption of chlorogenic acid on energy 
metabolism in normal weight male subjects; chlorogenic acid groups (BMI 21.9 + 
0.6 kg/m2) and control beverage (BMI 22.0 + 0.5 kg/m2). They reported there 
was no reduction in body weight (kg) or body fat (%), also resting fat oxidation 
rates were measured, however data was not reported suggesting no changes 
were made. The findings from this study are in agreement with the current 
study. The study involved a 4 week intervention, this may have been too short to 
show any effects, although the current study finds the same when extending the 
duration to 8 weeks. 
As previously mentioned, previous literature has shown that green coffee extract 
can potentially assist with the regulation of blood glucose levels. In a 
randomised crossover trial by Dijk et al, 2009, they investigated 4 supplements 
(12g decaffeinated coffee, 1g chlorogenic acid, 500mg trigonelline and placebo) 
in 15 overweight male subjects (BMI 25-35 kg/m2) and reported chlorogenic acid 
significantly reduced glucose concentrations at 15 minutes of an OGTT, 
compared to placebo. Furthermore, several studies have reported chlorogenic 
acid enriched coffee to be beneficial for type-2 diabetes mellitus (T2D), this is a 
metabolic disorder that involves impaired metabolism of glucose and fat. A 
systematic review and meta-analysis on the effects of decaffeinated coffee in 
relation of incidents of T2D reported that those who drank 3-4 cups of 
decaffeinated coffee containing high levels of chlorogenic acid reduced the risk 
of T2D by 30% (Huxley et al. 2009). Such analysis is, however, at risk of reverse 
causality and residual confounding due to its epidemiological design. 
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In addition, a more recent study by Katada et al, in 2018 investigated the effects 
of two different coffees; a chlorogenic acid enriched (CGA) coffee and a 
hydroxyhydroquinone (HHQ) reduced coffee on postprandial fat oxidation in 
healthy men. HHQ is an antioxidant component produced during the coffee-bean 
roasting process. The study was a randomised, double blind, placebo-controlled, 
crossover trial where 15 male volunteer (BMI 22.4 + 1.5 kg/m2) consumed either 
CGA (428mg) coffee for 4 weeks or CGA (382mg) containing HHQ, it is unclear 
why the CGA concentration differed between the coffee beverages. Postprandial 
energy metabolism was evaluated 300 minutes following a test meal using 
indirect calorimetry and blood samples were collected. Results showed that 
after the 4 week intervention, postprandial fat oxidation rates (11 + 17 vs 7 + 16 
mg/min) were higher in the CGA compared to the CGA containing HHQ, there 
was no changes in body mass or plasma metabolites such as glucose, insulin and 
high-density lipoproteins cholesterol or low-density lipoproteins cholesterol. 
According to the aforementioned studies above, resting fat oxidation rates do 
not seem to increase with chlorogenic enriched coffee however there is 
evidence for an increase in postprandial fat oxidation rates, although this does 
not result in a reduction in body fat. A possible reason for this discrepancy could 
be the short intervention period of only 4 weeks and the use of normal weight 
subjects, overweight or obese subjects may have accelerated the reduction. 
There have also been in vivo studies in mice which have investigated the effects 
of green coffee bean extract on body weight. Choi et al in 2016 induced obesity 
in mice with a high fat diet for four weeks then five groups were investigated; 
three different concentrations of green coffee bean extract (50, 100 and 200 
mg/kg) alongside a high fat diet, high fat diet alone and a control group which 
were fed a normal diet. The body weight gain in the high fat diet group alone 
were higher than in the control group, whereas, the mice fed a high fat diet 
alongside 100 and 200 mg/kg of green coffee extract reported reductions in body 
weight compared to the high fat diet alone. Similar findings were reported by 
Cho et al, 2010, they induced obesity in mice prior to their intervention where 
the mice were then randomly divided into four groups; normal fed diet, high fat 
diet, high fat diet plus 0.02% caffeic acid and a high fat diet plus 0.02% 
chlorogenic acid group and observed improvement in body weight. The caffeic 
acid and chlorogenic acid supplement groups reduced body weight by 8% and 16% 
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compared to the high fat diet alone group. Among the high fat diet fed groups, 
body weight gain was lower in the chlorogenic acid group compared to the high 
fat diet alone group or the caffeic acid supplement group. However, on the 
other hand, reports from Mubarak et al, 2013 and Li et al, 2014 observed that 
mice fed a high fat diet with green coffee extract failed to reduce body weight 
compared to a high fat diet alone. So as with the human data, the animal data is 
inconsistent in regards green coffee bean extract having any effect on body 
weight. 
Fat oxidation rates during exercise are up to 10-fold higher than at rest, this is 
due to the increasing energy demand of the working muscle (Achten and 
Jeukendrup, 2004). Prior to this current investigation there was no studies in the 
literature examining the effects of raspberry ketone during exercise and with 
very limited evidence regarding the effects green coffee bean extract has during 
exercise, more research is therefore required.  
Very few studies in the literature have examined the effects of green coffee 
extract with exercise. A study in 2015 by Beam et al, investigated the effects of 
post-exercise caffeine and green coffee bean extract consumption on blood 
glucose and insulin concentrations. Following the completion of a V̇O2 peak test,  
three bouts of 30-minute cycling were performed at 60% of peak power 1 week 
apart, subjects consumed 75g of dextrose with either 5 mg/kg body weight of 
caffeine, 10mg/kg of green coffee extract and 5 mg/kg body weight of dextrose 
as a placebo, immediately after exercise. A venous blood sample was taken pre 
exercise and an OGTT was performed post exercise. Indirect calorimetry was not 
measured during the OGTT, this could have been useful to see if the 
supplements had any changes in substrate utilisation. The results reported no 
differences in blood glucose and insulin between the two treatment groups. 
Although the current study did not perform an OGTT post exercise there was no 
difference in resting blood glucose or exercising blood glucose levels.   
Furthermore, Ota et al, 2010 investigated the effect of coffee polyphenols on 
energy metabolism, this was a double blind, placebo-controlled, crossover trial 
involving 7 male subjects, BMI 21.8 + 0.6 kg/m2. Subjects either consumed a 
coffee polyphenol test beverage (chlorogenic acid concentration was 
359mg/185g) or a control beverage containing no polyphenols for 1 week. 
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Indirect calorimetry was measured pre and post intervention both after fasting 
and up to 3.5 hours postprandial, and during exercise. The exercise was 
performed on a cycle ergometer, 20 watt warm up for 3 minutes then the work 
rate was increased 15 watts per minute until 60% of maximal heart rate was 
achieved. They found that the coffee polyphenol beverage led to significantly 
higher V̇O2 pre and post meal and during the exercise period, compared to the 
control beverage. Furthermore, the coffee polyphenol group had a higher fat 
oxidation rate 90 minutes after the meal compared to the control beverage. 
During exercise, the V̇O2 in the coffee polyphenol beverage group was higher in 
the warm up (20W for 3 minutes) and the first 2 minutes of the graded exercise 
session, compared to baseline. Fat oxidation during exercise tended to be higher 
in the coffee polyphenol beverage group, although there was no statistical 
difference, however the data was not reported, and this is in agreement with 
the present study. There was also no significant difference in fasting fat 
oxidation rates at rest between the treatment groups, this was similar to the 
current data.  
From the literature there are several randomised control trial investigating 
green coffee bean extract as an individual supplement. To my knowledge there 
are no clinical trials investigating the combined effects of green coffee bean 
extract with raspberry ketone. Although, a study by Stohs et al, in 2016 
investigated a novel weight loss supplement containing several ingredients 
including green coffee bean extract (300 mg & 45-50% chlorogenic acid), 
moringa oleifera leaf extract (200 mg), banana leaf extract (100 mg) and vitamin 
D3 (500 lU). The author claims the ingredients will suppress appetite, support 
weight management and weight loss and help maintain healthy blood sugar and 
lipid levels. This was a 60 day treatment intervention where 28 subjects 
consumed two capsules per day. The results demonstrated the product increased 
fat free mass and decreased body fat, but there were no changes in any of the 
blood measurements. A major limitation with this study was the failure to 
include a control group, if this was a randomised controlled trial the results 
would be more robust. Also subjects received a daily cash ‘incentive fee’ to 
ensure compliance.  
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Clinical trials investigating raspberry ketone are limited. Lopez et al, 2013 
reported significant reduction in body mass and fat mass following 8 weeks of 
consuming METABO versus placebo. METABO was a multi-ingredient weight loss 
product with raspberry ketone being one of many ingredients, the exact 
concentration is not reported, and other ingredients included caffeine, 
capsaicin, ginger and citrus. This was a randomised, placebo controlled, double 
blind study in 45 overweight individuals over 8 weeks (METABO group BMI = 30.8 
+ 2.5 kg/m2 versus 31.5 + 2.3 kg/m2 in the placebo group), this was carried out 
alongside a diet and exercise program; a calorie restricted diet of 500 
kilocalories less per day and performed three, 60-minute exercise sessions per 
week, and so the effect of the supplement alone is not clear. The participants in 
the METABO group reported a -2% decrease in body weight with the placebo 
group reporting a -0.5% decease, fat mass (-7.8% versus -2.8%), waist girth (-2.0% 
versus -0.2%) hip girth (-1.7% versus -0.4%) and an increase in lean mass (+3.4% 
versus +0/8%). No difference in glucose concentrations (mg/dL) between the 
METABO group and placebo were reported. Whether these effects were due to 
the raspberry ketones or one of the other supplement ingredients is not clear. 
4.2 Effects of Raspberry Ketone 
Most of the current literature investigating raspberry ketones has been carried 
out in animals, more evidence in humans is needed. A number of in vivo studies 
in the literature have shown similar observations to that of green coffee bean 
extract. Raspberry ketone has been shown to prevent and improve obesity in 
mice following a high fat diet. A study by Morimoto et al, 2005 reported that 
raspberry ketone prevented high fat diet induced increases in body weight 
versus a high fat diet alone. In the study mice were fed a high fat diet for 6 
weeks then signed to five groups; normal diet fed group, high fat diet groups and 
high fat diet plus three difference concentrations of raspberry ketone (2%, 1% 
and 0.5%). They reported in the high fat diet plus 2% raspberry ketone group, the 
body weight increase that took place over the initial 6 weeks on the high fat diet 
was reduced. In addition, a more recent study in 2017 investigated the effects of 
raspberry ketone on accumulation of adipose tissue, hepatic lipid storage and 
levels of plasma adiponectin in mice fed a high fat diet. Firstly mice were fed a 
high fat diet for 2 weeks to induce weight gain, following this they were 
randomly assigned to four experimental groups; high-dose raspberry ketone 
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(HRK, 1.74% RK wt/wt), low-dose raspberry ketone (LRK, 0.25% RK wt/wt), 
control and pair fed (PF) group, fed a similar food intake to the LRK mice. Mice 
were then fed for five weeks, results showed that mice fed LRK and HRK diets 
showed reduction in food intake and body weight compared to the mice on the 
control diet, the HRK diet exhibited decreases in inguinal fat mass and increased 
liver mass compared to the control group. However, plasma adiponectin 
concentration levels were not affected by raspberry ketone, reporting no 
significant changes between the groups (Cotten et al. 2017). With these animal 
studies reporting the same outcome as the animal studies conducted on mice 
with regards to green coffee bean extract, such that the supplement is only 
effective following a high fat diet to induce obesity, it could be hypothesised 
that similar to clinical trials conducted on green coffee bean extract in humans, 
raspberry ketone may also be more effective in overweight/obese individuals 
with a higher BMI. 
Regarding the effects raspberry ketone has on fat oxidation rates, there are no 
clinical trials in the current literature to my knowledge that have investigated 
this, either at rest or during exercise. There are a number of in vitro studies 
that report increases in fatty acid oxidation (Park 2010; Park 2015). Park in 2010 
investigated the effects of raspberry ketone on both lipolysis and fatty acid 
oxidation in 3T3-LI adipocytes in mice, it was observed that treatment with 10 
µM of raspberry ketone (99% purity), increased lipolysis and fatty acid oxidation, 
suppressed lipid accumulation, and increased secretion of adiponectin. These 
findings of increased secretion of adiponectin conflict with the study by Cotton 
et al in 2017. In 2015, Park investigated using 3T3-LI adipocytes, the effects of 
four different concentrations of raspberry ketone (1, 10, 20 and 50 µM) on 
adipogenic and liogenic gene expression. The results of the study showed that 
raspberry ketone inhibits the process of adipocyte differentiation as a results of 
a reduction in the expression of adipogenic and liopgenic genes. Raspberry 
ketone was also seen to enhance the expression of genes involved in lipolysis and 
the oxidative pathway, including adipose triglyceride lipase and hormone 
sensitive lipase. With some promising results from animal studies regarding the 
effects on fat oxidation, although the literature is still conflicting, you could 
proposed this effect may be seen in human populations, however more evidence 
is need in this area.  
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4.3 Study Limitations 
As in a lot of randomised controlled trials there are number of limitations with 
the current study. During the trial period participants were asked to consume 2 
capsules per day of the allocated supplement, maintain their regular lifestyle 
with regards to diet and exercise, and follow their food diary prior to the 
laboratory visits, the researcher kept in regular contact with the subjects 
however it is difficult to determine the level of compliance with these 
instruction. To ensure completion of the study in the allocated time, an 
intervention of 8 weeks was chosen, it may have been that a longer intervention 
is required before any effects are seen. In addition to ensure the target for the 
number subjects was achieved in the available time, a BMI >23 kg/m2 was 
chosen, it may have been, as shown by previous studies (which were not without 
limitation) that in an overweight or obese population effects of the supplement 
may have been seen. Finally the dose chosen for both dietary supplements was 
in accordance with previous studies in the literature, however due to the limited 
research in some areas it may be that a higher or lower concentration of the 
supplements could elicit a different effect. 
Due to time constraints, the current study, and other studies in the literature 
may be underpowered, increasing the subject numbers may prove successful in 
detecting significant differences in both substrate utilisation and body 
composition in normal weight individuals. The number of subjects for future 
studies should be based on an appropriately designed sample size calculation. A 
number of studies have investigated the effects of the supplements alongside a 
diet and exercise programme in overweight individuals, it is unlikely that 
supplementation alone will give the same reduction in body mass as seen in 
these previous studies. Therefore, it would be interesting to see if you get the 
same outcome with normal weight individuals by including a diet and exercise 
programme with the supplementation. It may be that an 8 week intervention is 
not long enough to see any positive results regarding weight loss, for example 
the study by Thom, in 2007 reported significant reduction in body mass following 
a 12 week intervention. Investigating different concentrations of the 
supplements may also be of interest to determine whether a dose-response 
relationship exist. The present study and other short term studies to date have 
reported no adverse events when consuming these food supplements, 
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intermediate and longer term effects are currently unknown, therefore a longer 
duration trial (exceeding 12 weeks) would be useful to determine how safe these 
supplements are. A better approach to the investigation of the impact on the 
regulation of glucose could be useful, an OGTT could be conducted pre (in the 
fasted state) and post exercise to give a greater understanding of this. In 
addition, the investigation of some metabolic health markers could be added to 
future studies, for example insulin, TAG, glycerol and non-esterified fatty acids. 
Further investigation into the effect these dietary supplements have during 
exercise, particularly raspberry ketone, is needed as there is limited research in 
this area. The steady state exercise test of 30 minutes may have been too short 
to identify any changes in energy substrate oxidation, therefore a longer 
exercise period could be considered. Also reporting the use of these supplements 
to improve performance could be of interest as research is limited. 
4.4 Conclusion 
In conclusion, this study demonstrated that following an 8 week treatment 
intervention of raspberry ketone, green coffee extract and a combination of 
these supplements together, alongside a control, there was no effect on body 
mass or body fat. Similarly, there was no difference in fat oxidation at rest or 
during exercise or plasma metabolites between the groups.  
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Appendices 
Appendix A: Health Screen for study volunteers 
UNIVERSITY OF GLASGOW  
COLLEGE OF MEDICAL, VETERINARY & LIFE SCIENCE  
SUBJECT QUESTIONNAIRE AND ASSENT FORM FOR EXERCISE TESTING 
  
If you feel unwell on the day of a proposed test, or have been feeling poorly within the last two 
weeks, you are excluded from taking part in an exercise test. The considerations that follow 
apply to people who have been feeling well for the preceding two weeks.  
 
NAME ……………………………………………..  
 
SEX: M/F AGE: ……. (yr) HEIGHT: ….… (m) WEIGHT: …… (kg)  
 
Details of last medical examination (where appropriate):  
 
Date: ……………..….(day/mo/yr) GP Location………………………………….………  
 
Exercise lifestyle:  
What kind(s) of exercise do you regularly do (20 min or more per session), and how often? 
(Please circle the number of times per average week):  
Walking   1  2   3   4   5  
Running   1 2  3  4  5  
Cycling   1  2  3  4  5  
Swimming   1  2  3  4  5  
Skiing    1 2  3  4  5  
Rowing   1  2  3  4  5  
Gymnastics   1  2  3  4  5  
Martial Arts   1  2  3  4  5  
Zumba etc..   1  2  3  4  5  
Aerobics  1  2  3  4  5  
HIIT training  1  2  3  4  5  
Weight Training  1  2  3  4  5  
Field Athletics   1  2  3  4  5  
Racket Sports   1  2  3  4  5  
Rugby/soccer/hockey   1  2  3  4  5  
Others*   1  2  3  4  5  
*(Please specify) 
..………………………………………………………………..………………………  
 
How long have you been exercising at least twice/week for at least 20 min/session? 
...…………… years  
 
Smoking: (Please tick one)              Never smoked ………  
Not for > 6 months ………  
Smoke < 10 per day ………  
Smoke > 10 per day ………  
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Illnesses: Have you ever had any of the following? (Please circle NO or YES)  
 
Anaemia   NO/YES    Asthma   NO/YES  
Diabetes   NO/YES    Epilepsy   NO/YES  
Heart Disease   NO/YES    High Blood Pressure  NO/YES  
Other*    NO/YES  
*(Please specify) 
……………………………………………………………..……………………….  
 
Symptoms:  
 
Have you ever had any of the following symptoms to a significant degree at rest or during 
exercise? That is, have you had to consult a physician relating to any of the following?  
 
    Rest     Exercise  
Breathlessness     NO/YES NO/YES  
Chest Pain     NO/YES NO/YES  
Dizzy Fits/Fainting   NO/YES NO/YES  
Heart Murmurs    NO/YES NO/YES  
Palpitations     NO/YES NO/YES  
Tightness in chest, jaw or arm   NO/YES NO/YES  
Other*      NO/YES  
*(Please specify) 
………………………………………………………………..……………………….  
 
Muscle or joint injury:  
Do you have/or have had any muscle or joint injury which could affect your safety in 
performing exercise (e.g. cycling or running), strength testing or strength training? 
 NO/YES*  
*(Please specify) 
………………………………………………………………..……………………….  
 
Medication:  
Are you currently taking any medication?  NO/YES*  
*(Please specify) 
………………………………………………………..…………………………………….  
 
 
Family History of Sudden Death:  
Is there a history of sudden death in people under 40 years in your family?  NO/YES*  
Can you think of any other reason why you should not take part in our tests?  
(Please specify) 
………………………………………………………………………...………………..  
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The following exclusion and inclusion criteria will apply to this study:  
Exclusion Criteria  
 
If you have any of the following, you will be excluded from the study:  
(a) Asthma, diabetes, epilepsy, heart disease, a family history of sudden death at a young age, 
fainting bouts, high blood pressure, anaemia and muscle or joint injury.  
(b) If you are taking any medication that may adversely affect your performance or health in 
this study, you will not be allowed to take part in the study.  
(c) If you take recreational drugs, you will not be allowed to take part in the study.  
(d) If you have ingested alcoholic drinks in the previous 48 hours, you will not be allowed to 
take part in the study. 
(e) If you are pregnant.  
 
Inclusion Criteria  
 
(a) Male or female subject aged at least 18 years and normally no more than 45 years.  
(b) In good health at the time of testing.  
 
 
Signature …………………………………..…. Date ……………………  
 
Body Weight and Blood Pressure:  
 
Body Weight: ………………………………… Height: ………………… 
BMI.............................. 
 
BP (Resting) ……………………………..……  
 
Screened by: ……………………..……………  
 
Date: ……………………………………..…… 
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Appendix B: Feedback form for study volunteers 
             
 
FEEDBACK FORM 
 
Please circle 
    
1. Have you been adhering to consuming 2 supplements per day with a meal?     Y/N 
If no please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
2. Has your diet remained ‘normal’?                                                                                Y/N 
If no please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
3. Has your physical activity level remained ‘normal’?               Y/N 
If no please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
4. Have you been feeling generally well?                             Y/N 
If no please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
5. Have you had any problems with your given supplement?           Y/N 
If yes please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
6. Have you had any adverse side effects with your given supplement?                Y/N 
(e.g. reduced appetite, nausea, abnormal sleeping pattern) 
If yes please note: 
_________________________________________________________________________
_________________________________________________________________________
____ 
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General comments 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
________ 
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